CA3084907A1 - Variants of fungal cellulase - Google Patents
Variants of fungal cellulase Download PDFInfo
- Publication number
- CA3084907A1 CA3084907A1 CA3084907A CA3084907A CA3084907A1 CA 3084907 A1 CA3084907 A1 CA 3084907A1 CA 3084907 A CA3084907 A CA 3084907A CA 3084907 A CA3084907 A CA 3084907A CA 3084907 A1 CA3084907 A1 CA 3084907A1
- Authority
- CA
- Canada
- Prior art keywords
- cellulase
- del
- variant polypeptide
- detergent
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940106157 cellulase Drugs 0.000 title claims abstract description 119
- 108010059892 Cellulase Proteins 0.000 title claims abstract description 113
- 230000002538 fungal effect Effects 0.000 title claims description 9
- 102000004190 Enzymes Human genes 0.000 claims abstract description 108
- 108090000790 Enzymes Proteins 0.000 claims abstract description 108
- 229940088598 enzyme Drugs 0.000 claims abstract description 108
- 239000003599 detergent Substances 0.000 claims abstract description 103
- 239000000203 mixture Substances 0.000 claims abstract description 83
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 79
- 229920001184 polypeptide Polymers 0.000 claims abstract description 75
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 75
- 230000000694 effects Effects 0.000 claims abstract description 47
- 108091005804 Peptidases Proteins 0.000 claims abstract description 35
- 239000004365 Protease Substances 0.000 claims abstract description 35
- 239000007788 liquid Substances 0.000 claims description 49
- 102220527696 Methyltransferase N6AMT1_N122A_mutation Human genes 0.000 claims description 35
- 239000004744 fabric Substances 0.000 claims description 30
- 238000006467 substitution reaction Methods 0.000 claims description 26
- 239000004753 textile Substances 0.000 claims description 26
- 239000000463 material Substances 0.000 claims description 24
- 108010084185 Cellulases Proteins 0.000 claims description 23
- 102000005575 Cellulases Human genes 0.000 claims description 23
- 239000000835 fiber Substances 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 23
- -1 DNAses Proteins 0.000 claims description 21
- 241000499912 Trichoderma reesei Species 0.000 claims description 20
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 19
- 229920002678 cellulose Polymers 0.000 claims description 17
- 239000001913 cellulose Substances 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 238000012217 deletion Methods 0.000 claims description 11
- 230000037430 deletion Effects 0.000 claims description 11
- 239000012634 fragment Substances 0.000 claims description 11
- 229920000742 Cotton Polymers 0.000 claims description 10
- 230000014509 gene expression Effects 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 108010065511 Amylases Proteins 0.000 claims description 9
- 102000013142 Amylases Human genes 0.000 claims description 9
- 235000019418 amylase Nutrition 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- 102000035195 Peptidases Human genes 0.000 claims description 8
- 241000223259 Trichoderma Species 0.000 claims description 8
- 108090001060 Lipase Proteins 0.000 claims description 7
- 102000004882 Lipase Human genes 0.000 claims description 7
- 239000004367 Lipase Substances 0.000 claims description 7
- 229940025131 amylases Drugs 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 7
- 235000019421 lipase Nutrition 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 6
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 6
- 239000000975 dye Substances 0.000 claims description 6
- 239000013604 expression vector Substances 0.000 claims description 6
- 150000007523 nucleic acids Chemical class 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 230000003287 optical effect Effects 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
- 239000002028 Biomass Substances 0.000 claims description 5
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 5
- 102000004316 Oxidoreductases Human genes 0.000 claims description 5
- 108090000854 Oxidoreductases Proteins 0.000 claims description 5
- 108010059820 Polygalacturonase Proteins 0.000 claims description 5
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 5
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- 239000000049 pigment Substances 0.000 claims description 5
- 101710152845 Arabinogalactan endo-beta-1,4-galactanase Proteins 0.000 claims description 4
- 241001619326 Cephalosporium Species 0.000 claims description 4
- 101710147028 Endo-beta-1,4-galactanase Proteins 0.000 claims description 4
- 108090000371 Esterases Proteins 0.000 claims description 4
- 241000223218 Fusarium Species 0.000 claims description 4
- 108010029541 Laccase Proteins 0.000 claims description 4
- 241001226034 Nectria <echinoderm> Species 0.000 claims description 4
- 102000003992 Peroxidases Human genes 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 4
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 239000007844 bleaching agent Substances 0.000 claims description 4
- 108010089934 carbohydrase Proteins 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- 108010005400 cutinase Proteins 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 108010087558 pectate lyase Proteins 0.000 claims description 4
- 230000002351 pectolytic effect Effects 0.000 claims description 4
- 102200012539 rs111033647 Human genes 0.000 claims description 4
- 102200005620 rs34282046 Human genes 0.000 claims description 4
- 102200081461 rs371856018 Human genes 0.000 claims description 4
- 102200027866 rs62514903 Human genes 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 claims description 4
- 108010011619 6-Phytase Proteins 0.000 claims description 3
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 3
- 241000194108 Bacillus licheniformis Species 0.000 claims description 3
- 241000194107 Bacillus megaterium Species 0.000 claims description 3
- 241000194103 Bacillus pumilus Species 0.000 claims description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 108700020962 Peroxidase Proteins 0.000 claims description 3
- 102220484282 T cell receptor alpha variable 34_E82R_mutation Human genes 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 238000003259 recombinant expression Methods 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 102200114273 rs199714731 Human genes 0.000 claims description 3
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 2
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 claims description 2
- 241000203809 Actinomycetales Species 0.000 claims description 2
- 241000235349 Ascomycota Species 0.000 claims description 2
- 241000228212 Aspergillus Species 0.000 claims description 2
- 241001513093 Aspergillus awamori Species 0.000 claims description 2
- 241000228245 Aspergillus niger Species 0.000 claims description 2
- 240000006439 Aspergillus oryzae Species 0.000 claims description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 2
- 241000304886 Bacilli Species 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- 241000123346 Chrysosporium Species 0.000 claims description 2
- 241001674013 Chrysosporium lucknowense Species 0.000 claims description 2
- 241000221760 Claviceps Species 0.000 claims description 2
- 241000221751 Claviceps purpurea Species 0.000 claims description 2
- 241001480006 Clavicipitaceae Species 0.000 claims description 2
- 241000221778 Fusarium fujikuroi Species 0.000 claims description 2
- 241000223221 Fusarium oxysporum Species 0.000 claims description 2
- 241001451172 Fusarium pseudograminearum Species 0.000 claims description 2
- 241000567178 Fusarium venenatum Species 0.000 claims description 2
- 241000233732 Fusarium verticillioides Species 0.000 claims description 2
- 241000223198 Humicola Species 0.000 claims description 2
- 241000223199 Humicola grisea Species 0.000 claims description 2
- 241001480714 Humicola insolens Species 0.000 claims description 2
- 241000257212 Hypocreomycetidae Species 0.000 claims description 2
- 241000235058 Komagataella pastoris Species 0.000 claims description 2
- 241000223201 Metarhizium Species 0.000 claims description 2
- 241000318910 Metarhizium acridum Species 0.000 claims description 2
- 241000223250 Metarhizium anisopliae Species 0.000 claims description 2
- 241000223608 Microascaceae Species 0.000 claims description 2
- 241000223607 Microascales Species 0.000 claims description 2
- 241000226677 Myceliophthora Species 0.000 claims description 2
- 241000147158 Nectriaceae Species 0.000 claims description 2
- 241000124176 Neocosmospora Species 0.000 claims description 2
- 241001529432 Ophiocordyceps Species 0.000 claims description 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 2
- 241001326562 Pezizomycotina Species 0.000 claims description 2
- 241000132889 Scedosporium Species 0.000 claims description 2
- 241000852049 Scedosporium apiospermum Species 0.000 claims description 2
- 241001326533 Sordariomycetes Species 0.000 claims description 2
- 241001279361 Stachybotrys Species 0.000 claims description 2
- 241001279364 Stachybotrys chartarum Species 0.000 claims description 2
- 241000557470 Stachybotrys chlorohalonata Species 0.000 claims description 2
- 241000187180 Streptomyces sp. Species 0.000 claims description 2
- 241001313536 Thermothelomyces thermophila Species 0.000 claims description 2
- 241001460073 Trichoderma asperellum Species 0.000 claims description 2
- 241000894120 Trichoderma atroviride Species 0.000 claims description 2
- 241000596490 Trichoderma citrinoviride Species 0.000 claims description 2
- 241000223260 Trichoderma harzianum Species 0.000 claims description 2
- 241000223262 Trichoderma longibrachiatum Species 0.000 claims description 2
- 241001342725 Trichoderma parareesei Species 0.000 claims description 2
- 241001149558 Trichoderma virens Species 0.000 claims description 2
- 241001474928 Ustilaginoidea virens Species 0.000 claims description 2
- 241001474927 Villosiclava Species 0.000 claims description 2
- 241000235015 Yarrowia lipolytica Species 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 239000000872 buffer Substances 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- 102220500059 eIF5-mimic protein 2_S54V_mutation Human genes 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 102220313179 rs1553259785 Human genes 0.000 claims description 2
- 102220311039 rs1556967227 Human genes 0.000 claims description 2
- 102200011359 rs727502766 Human genes 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 239000008247 solid mixture Substances 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 241000221775 Hypocreales Species 0.000 claims 1
- 239000003082 abrasive agent Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- 239000003518 caustics Substances 0.000 claims 1
- 238000005260 corrosion Methods 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 claims 1
- 102220105054 rs528902306 Human genes 0.000 claims 1
- 239000013042 solid detergent Substances 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 27
- 230000007774 longterm Effects 0.000 abstract description 6
- 125000000539 amino acid group Chemical group 0.000 abstract description 4
- 238000002474 experimental method Methods 0.000 abstract description 2
- 102000010909 Monoamine Oxidase Human genes 0.000 description 51
- 102200082910 rs34948328 Human genes 0.000 description 35
- 210000004027 cell Anatomy 0.000 description 28
- 235000001014 amino acid Nutrition 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 239000006229 carbon black Substances 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- 238000005406 washing Methods 0.000 description 15
- 150000001413 amino acids Chemical class 0.000 description 13
- 241001184659 Melanocarpus albomyces Species 0.000 description 12
- 102000040430 polynucleotide Human genes 0.000 description 11
- 108091033319 polynucleotide Proteins 0.000 description 11
- 239000002157 polynucleotide Substances 0.000 description 11
- 230000001461 cytolytic effect Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 229910001868 water Inorganic materials 0.000 description 9
- 235000002639 sodium chloride Nutrition 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 7
- 230000002255 enzymatic effect Effects 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- 102000004157 Hydrolases Human genes 0.000 description 6
- 108090000604 Hydrolases Proteins 0.000 description 6
- 108010076504 Protein Sorting Signals Proteins 0.000 description 6
- 229920000297 Rayon Polymers 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000027455 binding Effects 0.000 description 6
- 125000003147 glycosyl group Chemical group 0.000 description 6
- 230000003248 secreting effect Effects 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 230000009466 transformation Effects 0.000 description 6
- 230000003197 catalytic effect Effects 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108010038196 saccharide-binding proteins Proteins 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 239000012228 culture supernatant Substances 0.000 description 4
- 238000004851 dishwashing Methods 0.000 description 4
- 239000013613 expression plasmid Substances 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 240000008564 Boehmeria nivea Species 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 101000783705 Myxoma virus (strain Uriarra) Envelope protein A28 homolog Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920001131 Pulp (paper) Polymers 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 238000010804 cDNA synthesis Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000002964 rayon Substances 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 101150098636 A30L gene Proteins 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102220547849 Apoptosis-associated speck-like protein containing a CARD_K21Q_mutation Human genes 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 240000000491 Corchorus aestuans Species 0.000 description 2
- 235000011777 Corchorus aestuans Nutrition 0.000 description 2
- 235000010862 Corchorus capsularis Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 2
- 101710098247 Exoglucanase 1 Proteins 0.000 description 2
- 101710098246 Exoglucanase 2 Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 229920000433 Lyocell Polymers 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102220499174 Phosphatidylinositol 4-phosphate 5-kinase type-1 beta_H39S_mutation Human genes 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 229920002334 Spandex Polymers 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 108700005078 Synthetic Genes Proteins 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000004760 aramid Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 235000010338 boric acid Nutrition 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 108010091371 endoglucanase 1 Proteins 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000002979 fabric softener Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 108010020132 microbial serine proteinases Proteins 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000002708 random mutagenesis Methods 0.000 description 2
- 102220054390 rs727505023 Human genes 0.000 description 2
- 102220112074 rs72766563 Human genes 0.000 description 2
- 102220185599 rs781412138 Human genes 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000003724 sodium stearoyl-2-lactylate Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 244000198134 Agave sisalana Species 0.000 description 1
- 241000221832 Amorphotheca resinae Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 208000023514 Barrett esophagus Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 102220586486 Claudin-4_F35D_mutation Human genes 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101710126559 Endoglucanase EG-II Proteins 0.000 description 1
- 101710112457 Exoglucanase Proteins 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 101710194566 Glucoamylase P Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 101100170937 Mus musculus Dnmt1 gene Proteins 0.000 description 1
- 102220479489 NAD(+) hydrolase SARM1_P23R_mutation Human genes 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 238000001792 White test Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000002299 affinity electrophoresis Methods 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical group C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229920006231 aramid fiber Polymers 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000000085 cashmere Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000000224 chemical solution deposition Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000003926 complexometric titration Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 239000002761 deinking Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000009990 desizing Methods 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 108010091384 endoglucanase 2 Proteins 0.000 description 1
- 108010092450 endoglucanase Z Proteins 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000003248 enzyme activator Substances 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007730 finishing process Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000006081 fluorescent whitening agent Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 125000000487 histidyl group Chemical class [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000000050 mohair Anatomy 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 108091005763 multidomain proteins Proteins 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 238000002888 pairwise sequence alignment Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical class OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920006306 polyurethane fiber Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000013587 production medium Substances 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 102200142013 rs121909049 Human genes 0.000 description 1
- 102220136907 rs558993616 Human genes 0.000 description 1
- 102220054936 rs727504169 Human genes 0.000 description 1
- 102220075177 rs779736481 Human genes 0.000 description 1
- 102220062177 rs786202861 Human genes 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38645—Preparations containing enzymes, e.g. protease or amylase containing cellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
- D06M16/003—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic with enzymes or microorganisms
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2200/00—Functionality of the treatment composition and/or properties imparted to the textile material
- D06M2200/50—Modified hand or grip properties; Softening compositions
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Textile Engineering (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to polypeptides having cellulase activity, in particular to variants derived from the 20K-cellulase enzyme. The invention discloses a number of amino acid residue positions important for the properties of the cellulase enzyme and thereby for the stability and/or performance thereof. The novel variants have improved stability compared to the parental cellulase. In particular, the novel variants have good performance in an antigreying application and excellent stability in the presence of a protease in several detergent compositions even in long-term experiments.
Description
VARIANTS OF FUNGAL CELLULASE
FIELD OF THE INVENTION
The present invention relates to polypeptides having cellulase activity, in particular the invention relates to variants of cellulolytic enzymes that hydrolyze cellulose.
The enzymes have been engineered to have improved stability compared to the parent cellulase. Provided herein are novel polypeptide variants and the uses thereof.
BACKGROUND OF THE INVENTION
io Cellulases or cellulolytic enzymes are enzymes involved in hydrolysis of cellulose.
In the textile industry, cellulases are used in denim finishing to create a fashionable stone washed appearance in denim cloths in a biostoning process, and they are also used, for instance, to clean fuzz and prevent formation of pills on the surface of cotton garments. In detergent industry cellulases are used to brighten colors and to prevent graying, pilling of garments and to improve cleaning. Cellulases are further used in food industry and animal feed manufacturing, and they have a great potential in biomass hydrolysis and in the pulp and paper industry, for instance, in deinking to release ink from fiber surfaces and in improving pulp drainage.
The 20K-cellulase deriving from Melanocarpus albomyces has been used extensively for years in the textile and detergent industry and it has been a subject of several patents (for example EP0857216B1 and EP187492761). This cellulase has been shown to have good performance especially in antigreying applications.
The native 20K-cellulase molecule was cloned in the 1990's. Current increased demand on different washing systems for laundry has substantial consequences for the composition and amount of detergents needed.
Although cellulolytic enzymes have been used successfully in commercial applications for many years, a need still exists for new cellulases with altered properties, such as improved stability in detergent formulations containing protease.
BRIEF DESCRIPTION OF THE INVENTION
An object of the present invention is to provide novel variants of the 20K-cellulase that show improved performance and stability in detergent, when compared to the parental enzyme. The objects of the invention are achieved by a variant polypeptides and a method for their preparation and its uses which are characterized by what is stated in the independent claims. The preferred embodiments of the invention are disclosed in the dependent claims.
FIELD OF THE INVENTION
The present invention relates to polypeptides having cellulase activity, in particular the invention relates to variants of cellulolytic enzymes that hydrolyze cellulose.
The enzymes have been engineered to have improved stability compared to the parent cellulase. Provided herein are novel polypeptide variants and the uses thereof.
BACKGROUND OF THE INVENTION
io Cellulases or cellulolytic enzymes are enzymes involved in hydrolysis of cellulose.
In the textile industry, cellulases are used in denim finishing to create a fashionable stone washed appearance in denim cloths in a biostoning process, and they are also used, for instance, to clean fuzz and prevent formation of pills on the surface of cotton garments. In detergent industry cellulases are used to brighten colors and to prevent graying, pilling of garments and to improve cleaning. Cellulases are further used in food industry and animal feed manufacturing, and they have a great potential in biomass hydrolysis and in the pulp and paper industry, for instance, in deinking to release ink from fiber surfaces and in improving pulp drainage.
The 20K-cellulase deriving from Melanocarpus albomyces has been used extensively for years in the textile and detergent industry and it has been a subject of several patents (for example EP0857216B1 and EP187492761). This cellulase has been shown to have good performance especially in antigreying applications.
The native 20K-cellulase molecule was cloned in the 1990's. Current increased demand on different washing systems for laundry has substantial consequences for the composition and amount of detergents needed.
Although cellulolytic enzymes have been used successfully in commercial applications for many years, a need still exists for new cellulases with altered properties, such as improved stability in detergent formulations containing protease.
BRIEF DESCRIPTION OF THE INVENTION
An object of the present invention is to provide novel variants of the 20K-cellulase that show improved performance and stability in detergent, when compared to the parental enzyme. The objects of the invention are achieved by a variant polypeptides and a method for their preparation and its uses which are characterized by what is stated in the independent claims. The preferred embodiments of the invention are disclosed in the dependent claims.
2 The invention discloses a number of amino acid residue positions important for the stability of the 20K-cellulase enzyme and thereby for the performance thereof.
The present invention provides variant cellulase polypeptides basing on Melanocarpus albomyces 20K-cellulase core (without CBD). The novel variants have improved stability compared to the parent cellulase MAO, deriving from the 20K-cellulase. In particular, the novel variants have good performance in an antigreying application and excellent stability in the presence of a protease in several detergent compositions. Especially the variants show improved stability in protease containing detergents even in long-term experiments at elevated temperatures like lo 30 C and 37 C. In addition the yield of the variants in fermentation is comparable to parental cellulase MAO.
BRIEF DESCRIPTION OF THE DRAWINGS
In the following the invention will be described in greater detail by means of preferred embodiments with reference to the attached drawings, in which Figure 1 schematically shows the expression plasmid constructions for the expression of the MAO variants in Trichoderma reesei. Position of used promoter (Pcbh1), terminator (Tcbh1) and selection marker gene (amdS), relevant restriction sites and the position of the ampicillin resistance encoding gene (AmpR) in the vector are shown. Picture was generated using Geneious version 10.0 created by Biomatters.
Figure 2 shows the stability of variants MA79 and MA15 compared to parental cellulase MAO as residual activity in commercial liquid detergent after incubating samples at 50 C for 30 minutes in the presence of protease.
Figure 3 shows the antigreying performance of variant MA79 and parental cellulase MAO in a single wash in the presence of carbon black in a commercial liquid detergent. Washing conditions: 40 C, 60 min, 16 dH, carbon black approx.
0.15 g/I, detergent 4.4 g/I.
Figure 4A shows the stability of variant MA79 compared to parental cellulase MAO
as residual activity in commercial liquid detergent at 37 C in the presence of protease.
Figure 4B shows the stability of variant MA79 compared to parental cellulase MAO
as residual activity in commercial liquid detergent at 30 C in the presence of protease.
Figure 4C shows the stability of variant MA79 compared to parental cellulase MAO
as residual activity in commercial liquid detergent at room temperature (approx.
20-22 C) in the presence of protease.
The present invention provides variant cellulase polypeptides basing on Melanocarpus albomyces 20K-cellulase core (without CBD). The novel variants have improved stability compared to the parent cellulase MAO, deriving from the 20K-cellulase. In particular, the novel variants have good performance in an antigreying application and excellent stability in the presence of a protease in several detergent compositions. Especially the variants show improved stability in protease containing detergents even in long-term experiments at elevated temperatures like lo 30 C and 37 C. In addition the yield of the variants in fermentation is comparable to parental cellulase MAO.
BRIEF DESCRIPTION OF THE DRAWINGS
In the following the invention will be described in greater detail by means of preferred embodiments with reference to the attached drawings, in which Figure 1 schematically shows the expression plasmid constructions for the expression of the MAO variants in Trichoderma reesei. Position of used promoter (Pcbh1), terminator (Tcbh1) and selection marker gene (amdS), relevant restriction sites and the position of the ampicillin resistance encoding gene (AmpR) in the vector are shown. Picture was generated using Geneious version 10.0 created by Biomatters.
Figure 2 shows the stability of variants MA79 and MA15 compared to parental cellulase MAO as residual activity in commercial liquid detergent after incubating samples at 50 C for 30 minutes in the presence of protease.
Figure 3 shows the antigreying performance of variant MA79 and parental cellulase MAO in a single wash in the presence of carbon black in a commercial liquid detergent. Washing conditions: 40 C, 60 min, 16 dH, carbon black approx.
0.15 g/I, detergent 4.4 g/I.
Figure 4A shows the stability of variant MA79 compared to parental cellulase MAO
as residual activity in commercial liquid detergent at 37 C in the presence of protease.
Figure 4B shows the stability of variant MA79 compared to parental cellulase MAO
as residual activity in commercial liquid detergent at 30 C in the presence of protease.
Figure 4C shows the stability of variant MA79 compared to parental cellulase MAO
as residual activity in commercial liquid detergent at room temperature (approx.
20-22 C) in the presence of protease.
3 Figure 5 shows the stability of variant MA79 compared to parental cellulase MAO
as residual activity in commercial protease containing l&I detergent at 37 C.
Figure 6 shows the relative antigreying performance of variant MA79 compared to parental cellulase MAO after 88 d and 193 d storage in commercial liquid detergent in the presence of protease at 30 C.
Figure 7 shows the stability of variant MA79 compared to commercial cellulase Celluclean 5000L (Novozymes) as residual activity in commercial liquid detergent at 37 C in the presence of protease.
Figure 8A shows the stability of variant MA79 compared to parental cellulase MAO
and commercial cellulase Celluclean 5000L (Novozymes) as residual activity in protease containing liquid detergent concentrate at 37 C.
Figure 8B shows the stability of variant MA79 compared to parental cellulase MAO
and commercial cellulase Celluclean 5000L (Novozymes) as residual activity in protease containing liquid detergent concentrate at 30 C.
Figure 9 shows the stability of variants MA79, MA88, MA93 and MA103 compared to parental cellulase MAO as residual activity in commercial liquid detergent after incubating samples at 50 C for 24 h minutes in the presence of protease.
DETAILED DESCRIPTION OF THE INVENTION
Cellulolytic enzymes or cellulases are enzymes having cellulolytic activity, which means that they are capable of hydrolysing cellulosic substrates or derivatives thereof into smaller saccharides. Cellulolytic enzymes thus include both cellulases and hemicellulases. Cellulases include (1) endoglucanases (EG, EC 3.2.1.4) which cut internal beta-1,4-glucosidic bonds; (2) exoglucanases or cellobiohydrolases (CBH, EC 3.2.1.176, EC 3.2.1.91) that cut the dissaccharide cellobiose from the reducing or non-reducing end of the cellulose polymer chain and (3) beta-1,4-glucosidases (BG, EC 3.2.1.21) which hydrolyze the cellobiose and other short cello-oligosaccharides to glucose.
The present invention relates in particular to endoglucanases. Specifically, the present invention relates to fungal endoglucanases belonging to glycosyl hydrolase family 45 (Ce145), especially to variants of these endoglucanases.
More specifically, the invention relates to MAO cellulase variants deriving of Melanocarpus albomyces ALK04237 20 kDa endoglucanase. "Glycosyl hydrolase family 45" or "GH45" refers to the glycosyl hydrolase family as defined by Henrissat 1991, and Henrissat and Bairoch 1993, 1996.
The design of mutants is based on MAO cellulase 3D structure and sequence comparisons of Ce145 family enzymes. The amino acid and nucleotide sequences of Melanocarpus albomyces Ce145 20K-cellulase derived MAO is set forth in SEQ
as residual activity in commercial protease containing l&I detergent at 37 C.
Figure 6 shows the relative antigreying performance of variant MA79 compared to parental cellulase MAO after 88 d and 193 d storage in commercial liquid detergent in the presence of protease at 30 C.
Figure 7 shows the stability of variant MA79 compared to commercial cellulase Celluclean 5000L (Novozymes) as residual activity in commercial liquid detergent at 37 C in the presence of protease.
Figure 8A shows the stability of variant MA79 compared to parental cellulase MAO
and commercial cellulase Celluclean 5000L (Novozymes) as residual activity in protease containing liquid detergent concentrate at 37 C.
Figure 8B shows the stability of variant MA79 compared to parental cellulase MAO
and commercial cellulase Celluclean 5000L (Novozymes) as residual activity in protease containing liquid detergent concentrate at 30 C.
Figure 9 shows the stability of variants MA79, MA88, MA93 and MA103 compared to parental cellulase MAO as residual activity in commercial liquid detergent after incubating samples at 50 C for 24 h minutes in the presence of protease.
DETAILED DESCRIPTION OF THE INVENTION
Cellulolytic enzymes or cellulases are enzymes having cellulolytic activity, which means that they are capable of hydrolysing cellulosic substrates or derivatives thereof into smaller saccharides. Cellulolytic enzymes thus include both cellulases and hemicellulases. Cellulases include (1) endoglucanases (EG, EC 3.2.1.4) which cut internal beta-1,4-glucosidic bonds; (2) exoglucanases or cellobiohydrolases (CBH, EC 3.2.1.176, EC 3.2.1.91) that cut the dissaccharide cellobiose from the reducing or non-reducing end of the cellulose polymer chain and (3) beta-1,4-glucosidases (BG, EC 3.2.1.21) which hydrolyze the cellobiose and other short cello-oligosaccharides to glucose.
The present invention relates in particular to endoglucanases. Specifically, the present invention relates to fungal endoglucanases belonging to glycosyl hydrolase family 45 (Ce145), especially to variants of these endoglucanases.
More specifically, the invention relates to MAO cellulase variants deriving of Melanocarpus albomyces ALK04237 20 kDa endoglucanase. "Glycosyl hydrolase family 45" or "GH45" refers to the glycosyl hydrolase family as defined by Henrissat 1991, and Henrissat and Bairoch 1993, 1996.
The design of mutants is based on MAO cellulase 3D structure and sequence comparisons of Ce145 family enzymes. The amino acid and nucleotide sequences of Melanocarpus albomyces Ce145 20K-cellulase derived MAO is set forth in SEQ
4 ID NO: 1 and SEQ ID NO: 2, respectively. The isolation, enzymatic activity and industrial applications of 20K-cellulase are disclosed for example inEP1874927B1 and EP0857216B1 (AB Enzymes Oy).
The present invention specifically relates to a cellulase variant polypeptide, or an active fragment thereof, wherein the variant polypeptide has cellulase activity and comprises an amino acid sequence having at least 90%, but less than 100%
sequence identity to residues 22-235 of SEQ ID NO:1 comprising at least one substitution or deletion at one or more position selected from: 2, 22, 33, 35, 39, 44, 48, 54, 75, 82, 92, 99, 108, 122, 174, 175, 177, 194, 205, 206, 207, 208, 209, 210, io 211, 212, 213, and 214 wherein the amino acid positions of said variant polypeptide or active fragment thereof are numbered by correspondence with the mature amino acid sequence of SEQ ID NO:3.
The invention further relates to a polypeptide comprising one or more of the following substitutions or deletions in the cellulase amino acid sequence set forth in SEQ ID NO:1: N2W, N2R, G22A, G225, G22V, A33R, F35W, F35M, H39P, H395, V44R, V44Q, V44W, V44L, E48D, 554M, 554A, 554T, 554L, 554V A75H, A755, A75R, E825, E82R, E82W, T92I, A99Q, T1081, N122A, N122L, N1225, N122G, N122T, N122V, N1221, Q174R, N175D, D177Q, D177E, A194Q, G205T, F206H, A207R, A2075, del(A207-A214), del(V208-A214), del(F209-A214), del(K210-A214), del(A211-A214), del(P212-A214) and del(5213-A214) wherein the amino acid positions of said variant polypeptide are numbered by correspondence with the mature amino acid sequence of SEQ ID NO:3.
The invention further relates to a variant polypeptide, wherein the variant comprises a substitution at amino acid positions 22 and/or 122, wherein at position 22 G is preferably substituted to A, S or V, and at position 122 N is preferably substituted to A, S, G, T, V or I. In one embodiment the variant comprises a substitution at positions 22 and 122. It may additionally comprise at least one further substitution and/or deletion. The further substitution may be at a position selected from the following positions: 2, 35,44, 54, 75, 82, 108, 174, 177, 205, 206 and 207 and the deletion may be selected from the following: del(A207-A214), del(V208-A214), del(F209- A214), del(K210-A214), del(A211-A214), del(P212-A214) or del(5213-A214).
In the present invention the variants are derived from a parental molecule MAO
(SEQ ID NO: 2), which is a polynucleotide encoding for the catalytic core domain of a cellulase derived from Melanocarpus albomyces ALK04237 20K-cellulase having no cellulose binding domain (CBD).
The term "variant" as used herein refers to a polypeptide having cellulase activity and comprising an experimentally induced mutation, i.e., an insertion, substitution, and/or deletion, at one or more positions compared to the parental sequence MAO
set forth in SEQ ID NO:1. MAO differs from 20K-cellulase amino acid sequence by having a mutation in one specific position. A substitution means a replacement of an amino acid occupying a position with a different amino acid; a deletion means removal of an amino acid occupying a position; and an insertion means the addition
The present invention specifically relates to a cellulase variant polypeptide, or an active fragment thereof, wherein the variant polypeptide has cellulase activity and comprises an amino acid sequence having at least 90%, but less than 100%
sequence identity to residues 22-235 of SEQ ID NO:1 comprising at least one substitution or deletion at one or more position selected from: 2, 22, 33, 35, 39, 44, 48, 54, 75, 82, 92, 99, 108, 122, 174, 175, 177, 194, 205, 206, 207, 208, 209, 210, io 211, 212, 213, and 214 wherein the amino acid positions of said variant polypeptide or active fragment thereof are numbered by correspondence with the mature amino acid sequence of SEQ ID NO:3.
The invention further relates to a polypeptide comprising one or more of the following substitutions or deletions in the cellulase amino acid sequence set forth in SEQ ID NO:1: N2W, N2R, G22A, G225, G22V, A33R, F35W, F35M, H39P, H395, V44R, V44Q, V44W, V44L, E48D, 554M, 554A, 554T, 554L, 554V A75H, A755, A75R, E825, E82R, E82W, T92I, A99Q, T1081, N122A, N122L, N1225, N122G, N122T, N122V, N1221, Q174R, N175D, D177Q, D177E, A194Q, G205T, F206H, A207R, A2075, del(A207-A214), del(V208-A214), del(F209-A214), del(K210-A214), del(A211-A214), del(P212-A214) and del(5213-A214) wherein the amino acid positions of said variant polypeptide are numbered by correspondence with the mature amino acid sequence of SEQ ID NO:3.
The invention further relates to a variant polypeptide, wherein the variant comprises a substitution at amino acid positions 22 and/or 122, wherein at position 22 G is preferably substituted to A, S or V, and at position 122 N is preferably substituted to A, S, G, T, V or I. In one embodiment the variant comprises a substitution at positions 22 and 122. It may additionally comprise at least one further substitution and/or deletion. The further substitution may be at a position selected from the following positions: 2, 35,44, 54, 75, 82, 108, 174, 177, 205, 206 and 207 and the deletion may be selected from the following: del(A207-A214), del(V208-A214), del(F209- A214), del(K210-A214), del(A211-A214), del(P212-A214) or del(5213-A214).
In the present invention the variants are derived from a parental molecule MAO
(SEQ ID NO: 2), which is a polynucleotide encoding for the catalytic core domain of a cellulase derived from Melanocarpus albomyces ALK04237 20K-cellulase having no cellulose binding domain (CBD).
The term "variant" as used herein refers to a polypeptide having cellulase activity and comprising an experimentally induced mutation, i.e., an insertion, substitution, and/or deletion, at one or more positions compared to the parental sequence MAO
set forth in SEQ ID NO:1. MAO differs from 20K-cellulase amino acid sequence by having a mutation in one specific position. A substitution means a replacement of an amino acid occupying a position with a different amino acid; a deletion means removal of an amino acid occupying a position; and an insertion means the addition
5 of one or more amino acids. Deletions are described herein using "del"
before an indication of the first and last amino acid(s) deleted.
In an embodiment the polypeptide variant is a variant disclosed in Table 3 having the corresponding mutation as specified in Table 2. This embodiment is advantageous in obtaining variants that have improved stability in a detergent lo which contains protease. In a preferred embodiment the variant is a variant marked in Table 3 as having at least two "+" signs, even more preferably at least 3, 4 or even 5 "+" signs, the "+" signs indicating the level of improvement compared to the reference.
In a preferable embodiment the variant has at least three substitutions at positions 22, 54, and 122. More preferably the substitutions comprise substitutions G22A, 554T, and N122A (MA87).
In a preferable embodiment the variant has at least three substitutions at positions 22, 108, and 122. More preferably the substitutions comprise substitutions G22A, T1081, and N122A (MA93).
In a preferable embodiment the variant has at least three substitutions at positions 22, 122, 205. More preferably the substitutions comprise substitutions G22A, N122A, and G205T (MA103). Such variants have improved stability in a liquid detergent containing protease.
The polypeptide variant preferably comprises a sequence that is at least 90 %, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or at least 99% but less than 100%
identical to SEQ ID NO:1. In some embodiments, the disclosed variant sequence comprises at least one mutation and the remainder of the sequence is at least 90%
identical to the amino acid residues 22-235 set forth in SEQ ID NO: 1. As used herein, "identity" means the percentage of exact matches of amino acid residues between two aligned sequences over the number of positions where there are residues present in both sequences. When one sequence has a residue with no corresponding residue in the other sequence, the alignment program allows a gap in the alignment, and that position is not counted in the denominator of the identity calculation. Identity is a value determined with the Pairwise Sequence Alignment tool EMBOSS Needle at the EMBL-EBI website (www.ebi.ac.ukiToolsipsatem-boss_needleOwith the following parameters: BLOSUM62, Gap open 10, Gap extend 0.5.
The variants are generated by deliberately introducing changes in DNA to produce mutant gene products i.e. proteins. The changes or modifications of the parental
before an indication of the first and last amino acid(s) deleted.
In an embodiment the polypeptide variant is a variant disclosed in Table 3 having the corresponding mutation as specified in Table 2. This embodiment is advantageous in obtaining variants that have improved stability in a detergent lo which contains protease. In a preferred embodiment the variant is a variant marked in Table 3 as having at least two "+" signs, even more preferably at least 3, 4 or even 5 "+" signs, the "+" signs indicating the level of improvement compared to the reference.
In a preferable embodiment the variant has at least three substitutions at positions 22, 54, and 122. More preferably the substitutions comprise substitutions G22A, 554T, and N122A (MA87).
In a preferable embodiment the variant has at least three substitutions at positions 22, 108, and 122. More preferably the substitutions comprise substitutions G22A, T1081, and N122A (MA93).
In a preferable embodiment the variant has at least three substitutions at positions 22, 122, 205. More preferably the substitutions comprise substitutions G22A, N122A, and G205T (MA103). Such variants have improved stability in a liquid detergent containing protease.
The polypeptide variant preferably comprises a sequence that is at least 90 %, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or at least 99% but less than 100%
identical to SEQ ID NO:1. In some embodiments, the disclosed variant sequence comprises at least one mutation and the remainder of the sequence is at least 90%
identical to the amino acid residues 22-235 set forth in SEQ ID NO: 1. As used herein, "identity" means the percentage of exact matches of amino acid residues between two aligned sequences over the number of positions where there are residues present in both sequences. When one sequence has a residue with no corresponding residue in the other sequence, the alignment program allows a gap in the alignment, and that position is not counted in the denominator of the identity calculation. Identity is a value determined with the Pairwise Sequence Alignment tool EMBOSS Needle at the EMBL-EBI website (www.ebi.ac.ukiToolsipsatem-boss_needleOwith the following parameters: BLOSUM62, Gap open 10, Gap extend 0.5.
The variants are generated by deliberately introducing changes in DNA to produce mutant gene products i.e. proteins. The changes or modifications of the parental
6 nucleotide sequence may be introduced by several methods including e.g. site-directed and random mutagenesis, recombination or recombinant fusion engineering. For site-directed mutagenesis and fusion engineering a protein structure and good understanding of the structure-function relationship is beneficial. In the absence of such deep understanding, methods based on random mutagenesis may be used.
A variant may be obtained e.g. by altering hydrogen bond contacts, altering charge distribution, introduction of a salt bridge, introduction of metal binding sites, filling an internal structural cavity with one or more amino acids with bulkier side groups io (in e.g. regions which are structurally mobile), substitution of histidine residues with other amino acids, removal of a deamination site, removal of a flexible region, truncation of terminal region, shortening of a loop or by helix capping.
Stability of the protein may be improved by substitution of at least one amino acid with cysteine residue or insertion of one or more cysteine residues which creates at least one disulfide bridge.
The cellulase polypeptide variants of the invention are preferably recombinantly produced non-naturally occurring proteins. They are conveniently prepared using the generally known recombinant DNA technology. Briefly, the polynucleotide encoding the endoglucanase is cloned and inserted into an expression vector, transformed into a host cell and expressed. Preferably, mutations are introduced into the coding sequence with codons preferred by the host strain used.
Methods for protein production by recombinant technology in different host systems are well known in the art. Preferably, the polypeptide variants are produced as extracellular proteins that are secreted into the culture medium, from which they can easily be recovered and isolated.
The polypeptide variants may be designed to comprise in addition to the catalytic core domain, which forms the active or functional site of the enzyme, one or more "cellulose binding domains" ("CBDs"), also named as carbohydrate binding domains/modules (CBD/CBM) located either at the N- or C-terminus of the catalytic domain. CBMs have carbohydrate-binding activity and they mediate the binding of cellulase to crystalline and amorphous cellulose but have little or no effect on hydrolytic activity of the enzyme on soluble substrates.
The variants of the invention may optionally also contain a linker connecting the CBM and catalytic domain via a flexible and usually highly glycosylated region. By the term "linker" or "spacer" is meant a polypeptide comprising at least two amino acids which may be present between the domains of a multidomain protein, for example an enzyme comprising an enzyme core and a binding domain such as a carbohydrate binding module (CBM) or any other enzyme hybrid, or between two proteins or polypeptides produced as a fusion polypeptide, for example a fusion protein comprising two core enzymes. For example, the fusion protein of an
A variant may be obtained e.g. by altering hydrogen bond contacts, altering charge distribution, introduction of a salt bridge, introduction of metal binding sites, filling an internal structural cavity with one or more amino acids with bulkier side groups io (in e.g. regions which are structurally mobile), substitution of histidine residues with other amino acids, removal of a deamination site, removal of a flexible region, truncation of terminal region, shortening of a loop or by helix capping.
Stability of the protein may be improved by substitution of at least one amino acid with cysteine residue or insertion of one or more cysteine residues which creates at least one disulfide bridge.
The cellulase polypeptide variants of the invention are preferably recombinantly produced non-naturally occurring proteins. They are conveniently prepared using the generally known recombinant DNA technology. Briefly, the polynucleotide encoding the endoglucanase is cloned and inserted into an expression vector, transformed into a host cell and expressed. Preferably, mutations are introduced into the coding sequence with codons preferred by the host strain used.
Methods for protein production by recombinant technology in different host systems are well known in the art. Preferably, the polypeptide variants are produced as extracellular proteins that are secreted into the culture medium, from which they can easily be recovered and isolated.
The polypeptide variants may be designed to comprise in addition to the catalytic core domain, which forms the active or functional site of the enzyme, one or more "cellulose binding domains" ("CBDs"), also named as carbohydrate binding domains/modules (CBD/CBM) located either at the N- or C-terminus of the catalytic domain. CBMs have carbohydrate-binding activity and they mediate the binding of cellulase to crystalline and amorphous cellulose but have little or no effect on hydrolytic activity of the enzyme on soluble substrates.
The variants of the invention may optionally also contain a linker connecting the CBM and catalytic domain via a flexible and usually highly glycosylated region. By the term "linker" or "spacer" is meant a polypeptide comprising at least two amino acids which may be present between the domains of a multidomain protein, for example an enzyme comprising an enzyme core and a binding domain such as a carbohydrate binding module (CBM) or any other enzyme hybrid, or between two proteins or polypeptides produced as a fusion polypeptide, for example a fusion protein comprising two core enzymes. For example, the fusion protein of an
7 enzyme core with a CBM is provided by fusing a DNA sequence encoding the enzyme core, a DNA sequence encoding the linker and a DNA sequence encoding the CBM sequentially into one open reading frame and expressing this construct.
The modular structure of cellulases containing carbohydrate binding module and/or the linker region is well known in the art. The carbohydrate binding module and the linker region may be heterologous or homologous. "Heterologous" as used in the present context means that the CBM and/or the possible linker part of the variant polypeptides are obtained from a different organism than the cellulolytically active core domain. "Homologous" as used herein means that the CBM and/or the lo possible linker part of the variant are from the same organism as the cellulolytically active core. The invention discloses that any linker or CBM may be used in the variant polypeptide.
The variants of the invention may optionally also contain a signal sequence.
The term "signal sequence" denotes a DNA sequence that encodes a polypeptide (a "secretory peptide") that, as a component of a larger polypeptide, directs the larger polypeptide through a secretory pathway of a host cell in which it is produced. The secretory signal sequence can be native or it can be replaced with secretory signal sequence or carrier sequence from another source. Depending on the host cell, the larger peptide may be cleaved to remove the secretory peptide during transit through the secretory pathway.
"Enzymatically active fragment" refers to the part of a specific amino acid sequence that is long enough to have the desired enzymatic activity. In other words a fragment may be e.g. only the mature part of the polypeptide or even a subsequence of the mature part. It may or may not contain a linker and CBM
domain. The enzymatic activity refers herein to cellulolytic activity meaning catalytic ability of the polypeptide to hydrolyse cellulose or derivatives thereof.
The present invention relates further to novel polynucleotides which encode the cellulase variant polypeptide of the invention. The polynucleotide comprises a nucleotide sequence having SEQ ID NO: 2 or fragments thereof long enough to encode enzymatically active cellulase variants, or a sequence encoding a novel polypeptide variant as defined above, including complementary strands thereof.
The polynucleotides of the invention are recombinant molecules containing genetically engineered non-naturally occurring sequences. "Polynucleotide" as used herein refers to both RNA and DNA, and it may be single stranded or double stranded. It may also be complementary DNA (cDNA). With cDNA is meant a DNA
molecule synthesized from a messenger RNA template obtained from a eukaryotic or prokaryotic organism. Further, the polynucleotide may be degenerate as a result of the genetic code to any one of the sequences as defined above. This means that different codons may code for the same amino acid.
The modular structure of cellulases containing carbohydrate binding module and/or the linker region is well known in the art. The carbohydrate binding module and the linker region may be heterologous or homologous. "Heterologous" as used in the present context means that the CBM and/or the possible linker part of the variant polypeptides are obtained from a different organism than the cellulolytically active core domain. "Homologous" as used herein means that the CBM and/or the lo possible linker part of the variant are from the same organism as the cellulolytically active core. The invention discloses that any linker or CBM may be used in the variant polypeptide.
The variants of the invention may optionally also contain a signal sequence.
The term "signal sequence" denotes a DNA sequence that encodes a polypeptide (a "secretory peptide") that, as a component of a larger polypeptide, directs the larger polypeptide through a secretory pathway of a host cell in which it is produced. The secretory signal sequence can be native or it can be replaced with secretory signal sequence or carrier sequence from another source. Depending on the host cell, the larger peptide may be cleaved to remove the secretory peptide during transit through the secretory pathway.
"Enzymatically active fragment" refers to the part of a specific amino acid sequence that is long enough to have the desired enzymatic activity. In other words a fragment may be e.g. only the mature part of the polypeptide or even a subsequence of the mature part. It may or may not contain a linker and CBM
domain. The enzymatic activity refers herein to cellulolytic activity meaning catalytic ability of the polypeptide to hydrolyse cellulose or derivatives thereof.
The present invention relates further to novel polynucleotides which encode the cellulase variant polypeptide of the invention. The polynucleotide comprises a nucleotide sequence having SEQ ID NO: 2 or fragments thereof long enough to encode enzymatically active cellulase variants, or a sequence encoding a novel polypeptide variant as defined above, including complementary strands thereof.
The polynucleotides of the invention are recombinant molecules containing genetically engineered non-naturally occurring sequences. "Polynucleotide" as used herein refers to both RNA and DNA, and it may be single stranded or double stranded. It may also be complementary DNA (cDNA). With cDNA is meant a DNA
molecule synthesized from a messenger RNA template obtained from a eukaryotic or prokaryotic organism. Further, the polynucleotide may be degenerate as a result of the genetic code to any one of the sequences as defined above. This means that different codons may code for the same amino acid.
8 The present invention relates to a recombinant expression "vector" comprising a polynucleotide encoding the polypeptide variants as characterized above, operably linked to regulatory sequences, which are capable of directing the expression of a gene encoding said polypeptide variants in a suitable host. Said regulatory sequences may originate from the host organism or from another organism. The expression vector may further comprise marker genes for selection of the transformant strains or the selection marker may be introduced to the host in another vector construct by co-transformation.
Still the present invention relates to a production "host", which can be any organism lo capable of expressing the desired polypeptide. As used herein, "host cell"
means any cell type that is susceptible to transformation, transfection, transduction, mating, crossing or the like with a nucleic acid construct or expression vector comprising a polynucleotide. The term "host cell" encompasses any progeny that is not identical due to mutations that occur during replication. Non-limiting examples of a host cell are fungal cells, filamentous fungal cells from Division Ascomycota, Subdivision Pezizomycotina; preferably from the group consisting of members of the Class Sordariomycetes, Subclass Hypocreomycetidae, Orders Hypocrea/es and Microascales and Aspergillus, Chrysosporium, Myceliophthora and Humicola; more preferably from the group consisting of Families Hypocreacea, Nectriaceae, Clavicipitaceae, Microascaceae, and Genera Trichoderma (anamorph of Hypocrea), Fusarium, Gibberella, Nectria, Stachybotrys, Claviceps, Metarhizium, Villosiclava, Ophiocordyceps, Cephalosporium, and Scedosporium; more preferably from the group consisting of Trichoderma reesei (Hypocrea jecorina), T. citrinoviridae, T. longibrachiatum, T.
virens, T. harzianum, T. asperellum, T. atroviridae, T. parareesei, Fusarium oxysporum, F. gramineanum, F. pseudo graminearum, F. venenatum, Gibberella fujikuroi, G. moniliformis, G. zeaea, Nectria (Haematonectria) haematococca, Stachybotrys chartarum, S. chlorohalonata, Claviceps purpurea, Metarhizium acridum, M. anisopliae, Villosiclava virens, Ophiocordyceps sinensis, Acremonium (Cephalosporium) chrysogenum, and Scedosporium apiospermum, and Aspergillus niger, Aspergillus awamori, Aspergillus oryzae, Chrysosporium lucknowense, Myceli- ophthora thermophila, Humicola insolens, and Humicola grisea, most preferably Trichoderma reesei. Non-limiting examples of a host cell are yeasts (e.g. Saccharomyces cerevisiae, Pichia pastoris, Yarrowia lipolytica) and bacterial cells, preferably gram positive Bacilli (e.g. Bacillus subtilis, B.
licheniformis, B. megaterium, B. amyloliquefaciens, B. pumilus), gram-negative bacteria (e.g. Escherichia coli) and actinomycetales (e.g. Streptomyces sp.).
In an embodiment the host cell is a fungal cell, preferably a filamentous fungal cell, such as Trichoderma or Trichoderma reesei. In an embodiment the host cell is a bacterial cell, preferably a gram positive Bacillus cell, such as B. subtilis, B.
licheniformis, B. megaterium, B. amyloliquefaciens or B. pumilus.
Still the present invention relates to a production "host", which can be any organism lo capable of expressing the desired polypeptide. As used herein, "host cell"
means any cell type that is susceptible to transformation, transfection, transduction, mating, crossing or the like with a nucleic acid construct or expression vector comprising a polynucleotide. The term "host cell" encompasses any progeny that is not identical due to mutations that occur during replication. Non-limiting examples of a host cell are fungal cells, filamentous fungal cells from Division Ascomycota, Subdivision Pezizomycotina; preferably from the group consisting of members of the Class Sordariomycetes, Subclass Hypocreomycetidae, Orders Hypocrea/es and Microascales and Aspergillus, Chrysosporium, Myceliophthora and Humicola; more preferably from the group consisting of Families Hypocreacea, Nectriaceae, Clavicipitaceae, Microascaceae, and Genera Trichoderma (anamorph of Hypocrea), Fusarium, Gibberella, Nectria, Stachybotrys, Claviceps, Metarhizium, Villosiclava, Ophiocordyceps, Cephalosporium, and Scedosporium; more preferably from the group consisting of Trichoderma reesei (Hypocrea jecorina), T. citrinoviridae, T. longibrachiatum, T.
virens, T. harzianum, T. asperellum, T. atroviridae, T. parareesei, Fusarium oxysporum, F. gramineanum, F. pseudo graminearum, F. venenatum, Gibberella fujikuroi, G. moniliformis, G. zeaea, Nectria (Haematonectria) haematococca, Stachybotrys chartarum, S. chlorohalonata, Claviceps purpurea, Metarhizium acridum, M. anisopliae, Villosiclava virens, Ophiocordyceps sinensis, Acremonium (Cephalosporium) chrysogenum, and Scedosporium apiospermum, and Aspergillus niger, Aspergillus awamori, Aspergillus oryzae, Chrysosporium lucknowense, Myceli- ophthora thermophila, Humicola insolens, and Humicola grisea, most preferably Trichoderma reesei. Non-limiting examples of a host cell are yeasts (e.g. Saccharomyces cerevisiae, Pichia pastoris, Yarrowia lipolytica) and bacterial cells, preferably gram positive Bacilli (e.g. Bacillus subtilis, B.
licheniformis, B. megaterium, B. amyloliquefaciens, B. pumilus), gram-negative bacteria (e.g. Escherichia coli) and actinomycetales (e.g. Streptomyces sp.).
In an embodiment the host cell is a fungal cell, preferably a filamentous fungal cell, such as Trichoderma or Trichoderma reesei. In an embodiment the host cell is a bacterial cell, preferably a gram positive Bacillus cell, such as B. subtilis, B.
licheniformis, B. megaterium, B. amyloliquefaciens or B. pumilus.
9 A "recombinant cell" or "recombinant host cell" refers to a cell or host cell, which has been genetically modified or altered to comprise a nucleic acid sequence which is not native to said cell or host cell. In an embodiment the genetic modification comprises integrating the polynucleotide in the genome of the host cell. In another embodiment the polynucleotide is exogenous in the host cell.
The present invention relates also to a method for producing variant polypeptides of the invention, said method comprising the steps of transforming a host cell with an expression vector encoding said polypeptide, and culturing said host cell under conditions enabling production of said polypeptide, and optionally recovering and lo purifying said polypeptide. The production medium may be a medium suitable for growing the host organism and optionally containing inducers for efficient gene expression.
The present invention relates to an enzyme composition comprising the variant cellulase polypeptides of the invention. As used in the present context the "enzyme composition" refers to any enzyme product, preparation or composition, which comprises at least one of the novel variant cellulase polypeptides described herein.
Such an enzyme composition may be a spent culture medium or filtrate containing one or more variant cellulase polypeptides, or one or more variant cellulase polypeptides and one or more other enzymes. Spent culture medium means the culture medium of the host comprising the produced enzymes. Preferably the host cells are separated from said medium after the production. The enzyme composition may be a "whole culture broth" optionally after inactivating the production host(s) or microorganism(s) without any biomass separation, down-stream processing or purification of the desired cellulolytic enzyme(s), because the variant polypeptides can be secreted into the culture medium, and they display activity in the ambient conditions of the spent culture medium.
The enzyme composition may contain the enzymes in at least partially purified and isolated form. It may even essentially consist of the desired enzyme or enzymes.
If desired, the enzyme compositions may be dried, spray-dried or lyophilized, granulated or the enzymatic activity may be otherwise concentrated and/or stabilized for storage. If required, a desired enzyme may be crystallized or isolated or purified in accordance with conventional methods, such as filtration, extraction, precipitation, chromatography, affinity chromatography, electrophoresis, or the like.
In one embodiment of the present invention the enzyme composition further comprises one or more additional enzymes selected from the group consisting of protease, lipase, cutinase, amylase, carbohydrase, cellulase, pectinase, pectatelyase, pectinolytic enzyme, esterase, phytase, mannanase, arabinase, galactanase, xylanase, oxidase, xanthanase, xyloglucanase, DNAse, laccase, and/or peroxidase, preferably selected from the group consisting of proteases, amylases, cellulases and lipases.
The present enzyme composition comprising cellulase and an additional enzyme is advantageous in providing synergistic effects. Such additional enzymes are 5 desired when the present enzyme composition comprising cellulase is used in detergents e.g. when washing stains. Particularly advantageous synergistic enzymes that work with cellulases are amylases, proteases and mannanases, or a combination thereof, such as a composition comprising cellulase, amylase and protease. The perfect combination of enzymes allows maximal performance.
io In general the properties of the selected enzyme(s) should be compatible with the selected detergent, (i.e., pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts. In an embodiment the present enzyme composition further comprises:
a. at least one preservative selected from organic acids, e.g. benzoic acid, citric acid, ascorbic acid, sorbic acid, and salts thereof, sodium benzoate, hydroxybenzoate, benzisothiazolinone (BIT) or a combination thereof;
b. optionally at least one polyol selected from propylene glycol, glycerol, a sugar, sugar alcohol, sorbitol, hexylene glycol c. optionally at least one inhibitor selected from formic acid, lactic acid, boric acid, boric acid derivative, aromatic borate ester, phenyl boronic acid derivative, peptide, other reversible subtilisin inhibitors or a combination thereof;
d. optionally at least one enzyme selected from proteases, amylases, cellulases, lipases, xylanases, mannanases, cutinases, esterases, phytases, DNAses, pectinases, pectinolytic enzymes, pectate lyases, carbohydrases, arabinases, galactanases, xanthanases, xyloglucanase, laccases, peroxidases and oxidases with or without a mediator, or a combination thereof;
e. optionally at least one salt selected from sodium chloride, potassium chloride, potassium (hydrogen)phosphate, sodium (hydrogen)phosphate, ammonium sulfate, potassium sulfate, or a combination thereof; and f. optionally at least one filler or carrier selected from maltodextrin, flour, sodium chloride, sulfate, sodium sulfate, sodium acid pyrophosphate, tetra-sodium pyrophosphate, polyethylene glycol, or a combination thereof.
The additional components a-f provide improved properties for the present enzyme composition. The enzyme composition is compatible with the additional components and improves applicability of the enzyme composition in various uses.
Salts, such as sodium chloride and sodium sulfate function as drying aids.
In an embodiment the present enzyme composition is in the form of a liquid composition or a solid composition such as solution, dispersion, paste, powder, granule, granulate, coated granulate, tablet, cake, crystal, crystal slurry, gel or pellet.
The enzyme composition can be used in cleaning agents or boosters that are added on top of the detergent during or before the wash and that are for example in the form of liquid, gel, powder, granules or tablets. The enzyme composition and detergent components may also be soaked in a carrier like textiles.
In an embodiment the enzyme composition is used in textile and detergent io industry, biomass processing and biomass hydrolysis, preferably in biofuel, starch, pulp and paper, food, baking, feed or beverage industries.
The present invention relates further to a detergent composition comprising at least one of the novel variant cellulase polypeptides or an enzyme composition thereof.
The invention relates also to a use of the variant cellulase polypeptides of the invention in detergent applications. The terms "detergent composition" and "detergent" include, unless otherwise indicated, all washing agents in any form such as solid, granular or powder-form, liquid, gel or paste-form, and any combination thereof. The detergent composition may be in the form of a sachet, pouch, tablet or bar, including multi-compartment products. The detergent composition can be a free-flowing powder or a liquid. The terms include, unless otherwise stated, all-purpose or heavy-duty washing agents, especially cleaning detergents; liquid fine-fabric, specialty or low-duty detergents; hand dishwashing agents or light duty dishwashing agents, especially those of the high-foaming type;
machine dishwashing agents, including the various tablet, granular, liquid and rinse- aid types for household and institutional use; liquid cleaning and disinfecting agents, car or carpet shampoos, bathroom cleaners; metal cleaners; as well as cleaning auxiliaries such as bleach additives and "stain-stick" or pre-treat types, and laundry aids.
The terms "detergent", "detergent composition" and "detergent formulation" are used in reference to mixtures, which are intended for use in a wash medium for the cleaning of soiled objects. In some embodiments, the term is used in reference to laundering fabrics and/or garments (e.g., "laundry detergents"). In alternative embodiments, the term refers to other detergents, such as those used to clean dishes, cutlery, etc. (e.g., "dishwashing detergents"). It is not intended that the present invention be limited to any particular detergent formulation or composition.
It is intended that in addition to the cellulase variants according to the invention, the term encompasses detergents that may contain e.g., surfactants, builders, chelators or chelating agents, bleach system or bleach components, polymers, fabric conditioners, foam boosters, suds suppressors, dyes, perfume, tannish inhibitors, optical brighteners, bactericides, fungicides, soil suspending agents, anticorrosion agents, hydrotropes, fabric hueing agents, dispersants, dye transfer inhibiting agents, fluorescent whitening agents, soil release polymers, anti-redepositions agents, anti-shrink agents, anti-wrinkling agents, bactericides, binders, carriers, dyes, enzyme stabilizers, fabric softeners, fillers, foam regulators, perfumes, pigments, buffers, preservatives, sod suppressors, solvents, and structurants for liquid detergents, structure elasticizing agents, enzyme inhibitors or stabilizers, enzyme activators, transferase(s), hydrolytic enzymes, oxido reductases, bluing agents and fluorescent dyes, antioxidants, and solubilizers.
io A composition for use in solid laundry detergent, for example, may include 0.000001% - 5%, such as 0.000005-2%, such as 0.00001%-1%, such as 0.00001%-0.1`)/0 of variant cellulase polypeptide by weight of the composition.
A composition for use in laundry liquid, for example, may include 0.000001%-3%, such as 0.000005%-1%, such as 0.00001%-0.1% of variant cellulase polypeptide by weight of the composition.
A composition for use in automatic dishwash, for example, may include 0.000001%-5%, such as 0.000005%-2%, such as 0.00001%-1%, such as 0.00001%-0.1`)/0 of variant cellulase polypeptide by weight of the composition.
The detergent composition may be in the form of a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid. In one embodiment the detergent composition can be a laundry detergent composition, preferably a liquid or solid laundry detergent composition. There are a number of detergent formulation forms such as layers (same or different phases), pouches, as well as forms for machine dosing unit.
The variant cellulase polypeptides of the invention and enzyme compositions or detergent compositions containing them when used in detergent and textile industries have excellent performance and stability.
The term "stability" includes storage stability and stability during use, e.g.
during a wash process (in wash stability). The stability of the cellulase according to the invention is described as a function of time, e.g. how much activity is retained when the cellulase is kept in solution, in particular in a detergent solution.
The stability is influenced by many factors, e.g. pH, temperature, detergent composition e.g. proteases, stabilizers, builders, surfactants etc.
In the present invention the term "improved detergent stability" means that the cellulase variant retains its activity and/or performance in detergent solution, during storage and/or washing better than the parental enzyme. The stability may be assayed by determining the residual activity of the enzyme added to detergent after incubation at certain conditions for e.g. after 1 or several weeks incubation at 37 C or lower temperatures or after shorter time at 50 C, like described in Examples 2, 4 and 5. The residual activity of cellulase may be determined using the method described in Example 1 or any other method disclosed in the literature.
The stability may be measured also as wash performance after storage, e.g. as antigreying performance like described in Example 5.
The variant cellulase polypeptides and the enzyme compositions thereof may be used for treating any cellulosic material. In the present context, "cellulosic material"
io refers to any material comprising cellulose or derivatives thereof as a significant component. Such a material may be textile material, plants or material of plant origin used in food or animal feed, plant material for oil extraction, or wood-derived mechanical or chemical pulp or secondary fiber.
The term "textile" means any textile material including yarns, yarn intermediates, fibers, non-woven materials, natural materials, synthetic materials, and any other textile material, fabrics made of these materials and products made from fabrics (e.g., garments, linen and other articles). The textile or fabric may be in the form of knits, wovens, denims, non-wovens, felts, yarns, and towelling. The textile may be cellulose based, such as natural cellulosics including cotton, flax/linen, jute, ramie, sisal or coir or manmade cellulosics (e.g. originating from wood pulp) including viscose/rayon, ramie, cellulose acetate fibers (tricell), lyocell or blends thereof. The textile or fabric may also be non-cellulose based such as natural polyamides including wool, camel, cashmere, mohair, rabbit and silk or synthetic polymer such as nylon, aramid, polyester, acrylic, polypropylen and spandex/elastane, or blends thereof as well as blend of cellulose based and non-cellulose based fibers.
Examples of blends are blends of cotton and/or rayon/viscose with one or more companion material such as wool, synthetic fibers (e.g. polyamide fibers, acrylic fibers, polyester fibers, polyvinyl alcohol fibers, polyvinyl chloride fibers, polyurethane fibers, polyurea fibers, aramid fibers), and cellulose-containing fibers (e.g. rayon/viscose, ramie, flax/linen, jute, cellulose acetate fibers, lyocell). Fabric may be conventional washable laundry, for example stained household laundry.
When the term fabric or garment is used it is intended to include the broader term textiles as well.
The cellulosic material is reacted with the variant polypeptides of the invention or the enzyme composition comprising said variant polypeptides under suitable conditions, such as appropriate pH, and temperature, and the reaction is allowed to continue for a time sufficient for the enzymatic reaction to take place, whereby at least partially hydrolyzed cellulosic material is obtained. The enzymes are added in an enzymatically effective amount either simultaneously e.g. in the form of an enzyme mixture, or sequentially.
The variant cellulase polypeptides and the enzyme compositions containing them may be added to detergent compositions to improve textile cleaning, for instance by removal of pigment dirt and byantiredeposition and antigreying. The variant cellulases may also improve fiber and color care properties by prevention and removal of fuzz and pills resulting in brightening or freshening of colors and softening. The terms "depilling" (removal of pilling) and "color revival" are typically used to describe the cellulase effects on old, used cotton textiles. The terms "antipilling" (prevention of pilling), "color maintenance" or "color care" are typically used to describe cellulase effects on new garments. The effect of fiber and color lo care properties can be detected by visible and measurable decrease of lightness (i.e. increase of darkness) or change in color of colored cotton textiles exposed to repeated washing cycles. Standardized tests monitors of prepilled and unpilled, new fabrics are commercially available.
The variant endoglucanase polypeptides and the enzyme compositions containing them are especially useful in detergent applications as an anti-greying agent.
As used herein, the term "antigreying performance" or "antigreying effects" mean antiredepositioning and pigment removal properties. With increasing number of wash cycles, pigments, particles and soluble soils, salts and other material can adhere on the textile fibers, most likely in areas with damaged cotton fibers.
This can cause a greying effect and a darkening or yellowing of the cotton textile.
By theory, cellulases hydrolyze the cellulose chains in these areas at random positions with amorphous structure, leading to the removal of fibers with attached particles or higher accessibility for surfactants, and therefore showing a whitening or anti-greying effect. In addition, traces of cellulosic material in the washing liquor may be digested, preventing the adhesion of such fibers at the cotton surface of the garment. These effects are called antigreying or antiredeposition and can be evaluated using optical measurements. Suitable test methods are generally known in the art and are typically based on using artificial ballast soil systems with standard white test fabrics in repeated washing cycles in washing machines.
The antigreying effect can be tested also by a single wash as stressed test using redeposition liquid based on carbon black.
The variant cellulase polypeptides may also be added into detergent compositions to improve textile cleaning or stain removal by removal of pigmented dirt or by having synergistic effects on some stains with other enzymes typically used in detergents, like proteases, amylases, lipases, pectinases, and mannanases.
Stain removal effect can be measured as increased lightness or change of color of stained material, e.g. in artificially soiled swatches or test cloths by optical measurements and is visually detectable as fading of stains.
The variant cellulase polypeptides and the enzyme compositions containing them may also be useful in finishing processes of the textile industry, such as biofinishing of fabrics, garments or yarn. As used in the present context, the expression "biofinishing" (also called depilling, defuzzing, dehairing or biopolishing) refers to the use of the variant enzymes in a controlled hydrolysis of cellulosic fibers in order to modify the fabric or yarn surface in a manner that permanently prevents the tendency for pilling, improves fabric handle like softness and smoothness, clears 5 the surface structure by reducing fuzzing. Biofinishing results in clarification of colors, improves the drapability of the fabric and improves moisture absorbability, which may further improve also the dyeability. Biofinishing may be performed before, after or at the same time as dyeing.
Enzymatic depilling can be carried out at any stage during textile wet processing,
The present invention relates also to a method for producing variant polypeptides of the invention, said method comprising the steps of transforming a host cell with an expression vector encoding said polypeptide, and culturing said host cell under conditions enabling production of said polypeptide, and optionally recovering and lo purifying said polypeptide. The production medium may be a medium suitable for growing the host organism and optionally containing inducers for efficient gene expression.
The present invention relates to an enzyme composition comprising the variant cellulase polypeptides of the invention. As used in the present context the "enzyme composition" refers to any enzyme product, preparation or composition, which comprises at least one of the novel variant cellulase polypeptides described herein.
Such an enzyme composition may be a spent culture medium or filtrate containing one or more variant cellulase polypeptides, or one or more variant cellulase polypeptides and one or more other enzymes. Spent culture medium means the culture medium of the host comprising the produced enzymes. Preferably the host cells are separated from said medium after the production. The enzyme composition may be a "whole culture broth" optionally after inactivating the production host(s) or microorganism(s) without any biomass separation, down-stream processing or purification of the desired cellulolytic enzyme(s), because the variant polypeptides can be secreted into the culture medium, and they display activity in the ambient conditions of the spent culture medium.
The enzyme composition may contain the enzymes in at least partially purified and isolated form. It may even essentially consist of the desired enzyme or enzymes.
If desired, the enzyme compositions may be dried, spray-dried or lyophilized, granulated or the enzymatic activity may be otherwise concentrated and/or stabilized for storage. If required, a desired enzyme may be crystallized or isolated or purified in accordance with conventional methods, such as filtration, extraction, precipitation, chromatography, affinity chromatography, electrophoresis, or the like.
In one embodiment of the present invention the enzyme composition further comprises one or more additional enzymes selected from the group consisting of protease, lipase, cutinase, amylase, carbohydrase, cellulase, pectinase, pectatelyase, pectinolytic enzyme, esterase, phytase, mannanase, arabinase, galactanase, xylanase, oxidase, xanthanase, xyloglucanase, DNAse, laccase, and/or peroxidase, preferably selected from the group consisting of proteases, amylases, cellulases and lipases.
The present enzyme composition comprising cellulase and an additional enzyme is advantageous in providing synergistic effects. Such additional enzymes are 5 desired when the present enzyme composition comprising cellulase is used in detergents e.g. when washing stains. Particularly advantageous synergistic enzymes that work with cellulases are amylases, proteases and mannanases, or a combination thereof, such as a composition comprising cellulase, amylase and protease. The perfect combination of enzymes allows maximal performance.
io In general the properties of the selected enzyme(s) should be compatible with the selected detergent, (i.e., pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts. In an embodiment the present enzyme composition further comprises:
a. at least one preservative selected from organic acids, e.g. benzoic acid, citric acid, ascorbic acid, sorbic acid, and salts thereof, sodium benzoate, hydroxybenzoate, benzisothiazolinone (BIT) or a combination thereof;
b. optionally at least one polyol selected from propylene glycol, glycerol, a sugar, sugar alcohol, sorbitol, hexylene glycol c. optionally at least one inhibitor selected from formic acid, lactic acid, boric acid, boric acid derivative, aromatic borate ester, phenyl boronic acid derivative, peptide, other reversible subtilisin inhibitors or a combination thereof;
d. optionally at least one enzyme selected from proteases, amylases, cellulases, lipases, xylanases, mannanases, cutinases, esterases, phytases, DNAses, pectinases, pectinolytic enzymes, pectate lyases, carbohydrases, arabinases, galactanases, xanthanases, xyloglucanase, laccases, peroxidases and oxidases with or without a mediator, or a combination thereof;
e. optionally at least one salt selected from sodium chloride, potassium chloride, potassium (hydrogen)phosphate, sodium (hydrogen)phosphate, ammonium sulfate, potassium sulfate, or a combination thereof; and f. optionally at least one filler or carrier selected from maltodextrin, flour, sodium chloride, sulfate, sodium sulfate, sodium acid pyrophosphate, tetra-sodium pyrophosphate, polyethylene glycol, or a combination thereof.
The additional components a-f provide improved properties for the present enzyme composition. The enzyme composition is compatible with the additional components and improves applicability of the enzyme composition in various uses.
Salts, such as sodium chloride and sodium sulfate function as drying aids.
In an embodiment the present enzyme composition is in the form of a liquid composition or a solid composition such as solution, dispersion, paste, powder, granule, granulate, coated granulate, tablet, cake, crystal, crystal slurry, gel or pellet.
The enzyme composition can be used in cleaning agents or boosters that are added on top of the detergent during or before the wash and that are for example in the form of liquid, gel, powder, granules or tablets. The enzyme composition and detergent components may also be soaked in a carrier like textiles.
In an embodiment the enzyme composition is used in textile and detergent io industry, biomass processing and biomass hydrolysis, preferably in biofuel, starch, pulp and paper, food, baking, feed or beverage industries.
The present invention relates further to a detergent composition comprising at least one of the novel variant cellulase polypeptides or an enzyme composition thereof.
The invention relates also to a use of the variant cellulase polypeptides of the invention in detergent applications. The terms "detergent composition" and "detergent" include, unless otherwise indicated, all washing agents in any form such as solid, granular or powder-form, liquid, gel or paste-form, and any combination thereof. The detergent composition may be in the form of a sachet, pouch, tablet or bar, including multi-compartment products. The detergent composition can be a free-flowing powder or a liquid. The terms include, unless otherwise stated, all-purpose or heavy-duty washing agents, especially cleaning detergents; liquid fine-fabric, specialty or low-duty detergents; hand dishwashing agents or light duty dishwashing agents, especially those of the high-foaming type;
machine dishwashing agents, including the various tablet, granular, liquid and rinse- aid types for household and institutional use; liquid cleaning and disinfecting agents, car or carpet shampoos, bathroom cleaners; metal cleaners; as well as cleaning auxiliaries such as bleach additives and "stain-stick" or pre-treat types, and laundry aids.
The terms "detergent", "detergent composition" and "detergent formulation" are used in reference to mixtures, which are intended for use in a wash medium for the cleaning of soiled objects. In some embodiments, the term is used in reference to laundering fabrics and/or garments (e.g., "laundry detergents"). In alternative embodiments, the term refers to other detergents, such as those used to clean dishes, cutlery, etc. (e.g., "dishwashing detergents"). It is not intended that the present invention be limited to any particular detergent formulation or composition.
It is intended that in addition to the cellulase variants according to the invention, the term encompasses detergents that may contain e.g., surfactants, builders, chelators or chelating agents, bleach system or bleach components, polymers, fabric conditioners, foam boosters, suds suppressors, dyes, perfume, tannish inhibitors, optical brighteners, bactericides, fungicides, soil suspending agents, anticorrosion agents, hydrotropes, fabric hueing agents, dispersants, dye transfer inhibiting agents, fluorescent whitening agents, soil release polymers, anti-redepositions agents, anti-shrink agents, anti-wrinkling agents, bactericides, binders, carriers, dyes, enzyme stabilizers, fabric softeners, fillers, foam regulators, perfumes, pigments, buffers, preservatives, sod suppressors, solvents, and structurants for liquid detergents, structure elasticizing agents, enzyme inhibitors or stabilizers, enzyme activators, transferase(s), hydrolytic enzymes, oxido reductases, bluing agents and fluorescent dyes, antioxidants, and solubilizers.
io A composition for use in solid laundry detergent, for example, may include 0.000001% - 5%, such as 0.000005-2%, such as 0.00001%-1%, such as 0.00001%-0.1`)/0 of variant cellulase polypeptide by weight of the composition.
A composition for use in laundry liquid, for example, may include 0.000001%-3%, such as 0.000005%-1%, such as 0.00001%-0.1% of variant cellulase polypeptide by weight of the composition.
A composition for use in automatic dishwash, for example, may include 0.000001%-5%, such as 0.000005%-2%, such as 0.00001%-1%, such as 0.00001%-0.1`)/0 of variant cellulase polypeptide by weight of the composition.
The detergent composition may be in the form of a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid. In one embodiment the detergent composition can be a laundry detergent composition, preferably a liquid or solid laundry detergent composition. There are a number of detergent formulation forms such as layers (same or different phases), pouches, as well as forms for machine dosing unit.
The variant cellulase polypeptides of the invention and enzyme compositions or detergent compositions containing them when used in detergent and textile industries have excellent performance and stability.
The term "stability" includes storage stability and stability during use, e.g.
during a wash process (in wash stability). The stability of the cellulase according to the invention is described as a function of time, e.g. how much activity is retained when the cellulase is kept in solution, in particular in a detergent solution.
The stability is influenced by many factors, e.g. pH, temperature, detergent composition e.g. proteases, stabilizers, builders, surfactants etc.
In the present invention the term "improved detergent stability" means that the cellulase variant retains its activity and/or performance in detergent solution, during storage and/or washing better than the parental enzyme. The stability may be assayed by determining the residual activity of the enzyme added to detergent after incubation at certain conditions for e.g. after 1 or several weeks incubation at 37 C or lower temperatures or after shorter time at 50 C, like described in Examples 2, 4 and 5. The residual activity of cellulase may be determined using the method described in Example 1 or any other method disclosed in the literature.
The stability may be measured also as wash performance after storage, e.g. as antigreying performance like described in Example 5.
The variant cellulase polypeptides and the enzyme compositions thereof may be used for treating any cellulosic material. In the present context, "cellulosic material"
io refers to any material comprising cellulose or derivatives thereof as a significant component. Such a material may be textile material, plants or material of plant origin used in food or animal feed, plant material for oil extraction, or wood-derived mechanical or chemical pulp or secondary fiber.
The term "textile" means any textile material including yarns, yarn intermediates, fibers, non-woven materials, natural materials, synthetic materials, and any other textile material, fabrics made of these materials and products made from fabrics (e.g., garments, linen and other articles). The textile or fabric may be in the form of knits, wovens, denims, non-wovens, felts, yarns, and towelling. The textile may be cellulose based, such as natural cellulosics including cotton, flax/linen, jute, ramie, sisal or coir or manmade cellulosics (e.g. originating from wood pulp) including viscose/rayon, ramie, cellulose acetate fibers (tricell), lyocell or blends thereof. The textile or fabric may also be non-cellulose based such as natural polyamides including wool, camel, cashmere, mohair, rabbit and silk or synthetic polymer such as nylon, aramid, polyester, acrylic, polypropylen and spandex/elastane, or blends thereof as well as blend of cellulose based and non-cellulose based fibers.
Examples of blends are blends of cotton and/or rayon/viscose with one or more companion material such as wool, synthetic fibers (e.g. polyamide fibers, acrylic fibers, polyester fibers, polyvinyl alcohol fibers, polyvinyl chloride fibers, polyurethane fibers, polyurea fibers, aramid fibers), and cellulose-containing fibers (e.g. rayon/viscose, ramie, flax/linen, jute, cellulose acetate fibers, lyocell). Fabric may be conventional washable laundry, for example stained household laundry.
When the term fabric or garment is used it is intended to include the broader term textiles as well.
The cellulosic material is reacted with the variant polypeptides of the invention or the enzyme composition comprising said variant polypeptides under suitable conditions, such as appropriate pH, and temperature, and the reaction is allowed to continue for a time sufficient for the enzymatic reaction to take place, whereby at least partially hydrolyzed cellulosic material is obtained. The enzymes are added in an enzymatically effective amount either simultaneously e.g. in the form of an enzyme mixture, or sequentially.
The variant cellulase polypeptides and the enzyme compositions containing them may be added to detergent compositions to improve textile cleaning, for instance by removal of pigment dirt and byantiredeposition and antigreying. The variant cellulases may also improve fiber and color care properties by prevention and removal of fuzz and pills resulting in brightening or freshening of colors and softening. The terms "depilling" (removal of pilling) and "color revival" are typically used to describe the cellulase effects on old, used cotton textiles. The terms "antipilling" (prevention of pilling), "color maintenance" or "color care" are typically used to describe cellulase effects on new garments. The effect of fiber and color lo care properties can be detected by visible and measurable decrease of lightness (i.e. increase of darkness) or change in color of colored cotton textiles exposed to repeated washing cycles. Standardized tests monitors of prepilled and unpilled, new fabrics are commercially available.
The variant endoglucanase polypeptides and the enzyme compositions containing them are especially useful in detergent applications as an anti-greying agent.
As used herein, the term "antigreying performance" or "antigreying effects" mean antiredepositioning and pigment removal properties. With increasing number of wash cycles, pigments, particles and soluble soils, salts and other material can adhere on the textile fibers, most likely in areas with damaged cotton fibers.
This can cause a greying effect and a darkening or yellowing of the cotton textile.
By theory, cellulases hydrolyze the cellulose chains in these areas at random positions with amorphous structure, leading to the removal of fibers with attached particles or higher accessibility for surfactants, and therefore showing a whitening or anti-greying effect. In addition, traces of cellulosic material in the washing liquor may be digested, preventing the adhesion of such fibers at the cotton surface of the garment. These effects are called antigreying or antiredeposition and can be evaluated using optical measurements. Suitable test methods are generally known in the art and are typically based on using artificial ballast soil systems with standard white test fabrics in repeated washing cycles in washing machines.
The antigreying effect can be tested also by a single wash as stressed test using redeposition liquid based on carbon black.
The variant cellulase polypeptides may also be added into detergent compositions to improve textile cleaning or stain removal by removal of pigmented dirt or by having synergistic effects on some stains with other enzymes typically used in detergents, like proteases, amylases, lipases, pectinases, and mannanases.
Stain removal effect can be measured as increased lightness or change of color of stained material, e.g. in artificially soiled swatches or test cloths by optical measurements and is visually detectable as fading of stains.
The variant cellulase polypeptides and the enzyme compositions containing them may also be useful in finishing processes of the textile industry, such as biofinishing of fabrics, garments or yarn. As used in the present context, the expression "biofinishing" (also called depilling, defuzzing, dehairing or biopolishing) refers to the use of the variant enzymes in a controlled hydrolysis of cellulosic fibers in order to modify the fabric or yarn surface in a manner that permanently prevents the tendency for pilling, improves fabric handle like softness and smoothness, clears 5 the surface structure by reducing fuzzing. Biofinishing results in clarification of colors, improves the drapability of the fabric and improves moisture absorbability, which may further improve also the dyeability. Biofinishing may be performed before, after or at the same time as dyeing.
Enzymatic depilling can be carried out at any stage during textile wet processing,
10 preferably after optional desizing and/or bleaching, and similar conditions as in biostoning can be used. Textiles in garment form can be also treated.
The variant cellulase polypeptides and enzyme compositions containing them may be used in biostoning of denim. As used in the present context, the expression "biostoning" of fabric or garment means the use of enzymes in place of, or in 15 addition to, pumice stones for the treatment of fabric or garment, especially denim to obtain an aged or worn look. The term "aged or worn look" means that as a result of uneven dye removal, there are contrasts between dyed areas and areas from which dye has been removed.
The liquor ratio (the ratio of the volume of liquid per weight of fabric) in both biostoning and biofinishing may range from about 3:1 to 20:1, preferably 5:1 to 10:1. The treatment time can vary between 15 min to 90 min and preferably between 30 min to 60 min. It should be emphasized that the enzyme dosage greatly depends on the type of the fabrics, machinery, process conditions (pH, temperature, liquor ratio, treatment time, denim load, process scale) and type of the enzyme preparation or composition. Typical process parameters for e.g.
industrial biofinishing are pH 4.5 - 8 at temperature of 40 - 65 C. A person skilled in art is capable in defining suitable dosages and conditions.
SEQUENCE LISTING
SEQ ID NO:1 The full-length amino acid sequence of MAO cellulase deriving from the Melanocarpus albomyces ALK04237 GH45 20K-cellulase including amino acids from Met1 to Ala235.
SEQ ID NO:2 The nucleotide sequence of the full-length MAO cellulase deriving from Melanocarpus albomyces ALK04237 ce145 20K-cellulase.
SEQ ID NO:3 The amino acid sequence of the mature MAO cellulase deriving from the Melanocarpus albomyces ALK04237 GH45 20K-cellulase including amino acids from Alai to Ala214.
DEPOSITS
Melanocarpus albomyces ALK04237 was deposited at the Centraalbureau Voor Schimmelcultures at Upsalalaan 8, 3584 CT, Utrecht, The Netherlands on 2 March 2012 and assigned accession number CBS132099.
EXAMPLES
Standard molecular biology methods were used in the isolation and enzyme treatments of DNA (e.g. isolation of plasmid DNA, digestion of DNA to produce DNA fragments), in E. coli transformations, sequencing etc. The basic laboratory methods used were either as described by the enzyme, reagent or kit manufacturer or as described in the standard molecular biology handbooks, e.g. Sambrook and Russell (2001) or as described in the following examples.
Example 1. Production of Melanocarpus albomyces MAO variants in Trichoderma reesei Melanocarpus albomyces ce/45 20K-cellulase variants were derived from a parental molecule, designated here as MAO (nucleic acid sequence SEQ ID NO:
2, corresponding to amino acid sequence SEQ ID NO: 1). Expression plasmids were constructed for production of recombinant ce/45 MAO variants (Figure 1).
The constructs contain T. reesei cei7A promoter and terminator and the amdS marker gene as described in Paloheimo et al. 2003. The variant genes contain a signal sequence at position 1-63 nt and intron sequences at positions 84-154 nt and 473 nt. Synthetic genes, including mutations introduced in the core region of the parental molecule (Table 1), were exactly fused as SacII-BamH1 fragments to the T. reesei ce/7A promoter by ligation. For construction of the expression plasmid for MA79 variant a 328 bp Sall - BamHI fragment of pALK4472 was isolated and ligated into a 8523 bp Sall - BamHI fragment of pALK4458. Expression plasm ids are listed in Table 1.
Table 1. The synthetic genes used in construction of the expression cassettes for production of MAO cellulase variants in T. reesei. Amino acid positions are numbered by correspondence with the mature amino acid sequence without signal sequence (SEQ ID NO: 3).
Gene/ variant Expression Mutation designation plasmid MA1 G22A pALK4458 MA2 P23R pALK4459 MA3 F35W pALK4460 MA4 F35D pALK4461 MA5 H39S pALK4462 MA6 H39P pALK4463 MA7 A43S pALK4464 MA8 V44R, E48D pALK4465 MA9 V44Q pALK4466 MA10 F53Y pALK4467 MA11 A62S pALK4468 MA13 E82S pALK4470 MA14 A99Q pALK4471 MA15 N122A pALK4472 MA16 N122L pALK4473 MA17 L130G pALK4474 MA18 P136S pALK4475 MA19 S151D pALK4476 MA20 Q153S pALK4477 MA21 D156S pALK4478 MA22 P161S pALK4479 MA24 V193T pALK4481 MA25 V193D pALK4482 MA26 A194Q pALK4483 MA27 F206Y pALK4484 MA28 S54M, N122A pALK4485 MA29 G22A, E82S pALK4486 MA30 F35W, H39P pALK4487 MA31 H39S, V44Q pALK4488 MA32 A43S, F53Y pALK4489 MA35 F53T, P136S pALK4492 MA37 V44R, E48D, G22A, E82S pALK4494 MA40 A19D pALK4497 MA41 K21E pALK4498 MA42 K21Q pALK4499 MA43 G2OR pALK4209 MA44 S3OL pALK4210 MA45 S3OP pALK4211 MA46 A33R pALK4212 MA47 F35M pALK4213 MA48 Q36R pALK4214 MA49 V44 L pALK4215 MA50 E481 pALK4216 MA52 A75S pALK4218 MA53 A75H pALK4219 MA54 T92I pALK4220 MA55 T94 R pALK4221 MA56 T1081 pALK4222 MA57 F131I pALK4223 MA59 Q174H pALK4225 MA60 N175D pALK4226 MA61 D177Q pALK4227 MA62 Vi 931 pALK4228 MA63 A194S pALK4229 MA64 G205R pALK4230 MA65 A207R pALK4231 MA66 A207S pALK4232 MA67 A33L pALK4233 MA68 Q36H pALK4234 MA69 V44L, E481 pALK4235 MA70 A33L, F35M, Q36R pALK4236 MA71 N175D, D177Q pALK4237 MA72 T92I, T94R pALK4238 MA73 G205R, A207S pALK4239 MA74 P1240, G1650 pALK4240 MA75 S5C, F119C, V1051 pALK4241 MA76 F350, A560 pALK4242 MA77 S680, M1030, V1051 pALK4243 MA78 V1860, A2070 pALK4244 MA79 G22A, N122A pALK4621 MA80 N122S pALK4718 MA81 N122G pALK4719 MA82 N122T pALK4720 MA83 N122V pALK4721 MA84 N122I pALK4722 MA85 G22S pALK4723 MA86 G22V pALK4724 MA87 G22A, S54A, N122A pALK4725 MA88 G22A, S54T, N122A pALK4726 MA89 G22A, S54L, N122A pALK4727 MA90 G22A, S54V, N122A pALK4728 MA91 G22A, E82R, N122A pALK4729 MA92 G22A, E82W, N122A pALK4730 MA93 G22A, T1081, N122A pALK4731 MA94 G22A, V44R, N122A pALK4732 MA95 G22A, V44W, N122A pALK4733 MA96 G22A, V44L, N122A pALK4734 MA97 G22A, A75S, N122A pALK4735 MA98 G22A, A75R, N122A pALK4736 MA99 G22A, F35M, N122A pALK4737 MA100 N2W, G22A, N122A pALK4738 MA101 N2R, G22A, N122A pALK4739 MA102 G22A, N122A, Q174R pALK4740 MA103 G22A, N122A, G205T pALK4741 MA104 G22A, F35W, A75H, T1081, N122A, A207S pALK4742 MA107 G22A, N122A, Q174R, D177E pALK4745 MA109 G22A, N122A, F206H pALK4748 MA110 G22A, N122A, del(A207-A214) pALK4749 MA111 G22A, N122A, del(V208-A214) pALK4750 MA112 G22A, N122A, del(F209-A214) pALK4751 MA113 G22A, N122A, del(K210-A214) pALK4752 MA114 G22A, N122A, del(A211-A214) pALK4753 MA115 G22A, N122A, del(P212-A214) pALK4754 MA116 G22A, N122A, del(S213-A214) pALK4755 The linear expression cassette was isolated from the vector backbone by EcoRI
digestion or the circular plasmid was used directly in T. reesei protoplast transformation. The transformants were selected with acetamide as the sole nitrogen source. The host strain lacks the four major endogenous cellulases:
CBHI/Cel7A, CBHII/Cel6A, EGI/Cel7B and EGII/Cel5A. The transformations were performed according to Penttila et al, 1987, with the modifications described in Karhunen et al., 1993. The transformants were purified on selection plates through single conidia prior to sporulating them on potato dextrose agar.
The cellulase production of the transformants was analyzed from the culture supernatants of shake flask cultivations (50 ml). The transformants were grown for 7 days at 3000, 250 rpm in a complex cellulase-inducing medium (Joutsjoki et al., 1993) buffered with 5% KH2PO4 at pH 5.5. The enzyme activity of the recombinant protein was measured from the culture supernatant as the release of reducing sugars from carboxymethylcellulose (3% CMC) at 50 C in 50 mM HEPES buffer pH 7.0 essentially as described by Bailey and Nevalainen, 1981; Haakana, et al, 2004 (NCU activity). Production of the recombinant protein was also detected from the culture supernatant by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Chosen transformants and the reference strain producing the parental MAO
cellulase were cultivated in shake flasks or bioreactors in complex cellulase-inducing medium to obtain material for the application tests (Examples 2 to 6).
Example 2. Screening of MAO variants MAl-MA79 based on their stability in commercial liquid detergent at 50 C
MAO variants produced in Trichoderma as described in Example 1 were screened based on detergent stability at 50 C by a rapid test in the presence of protease.
Parental cellulase MAO was used as reference. A 0.8% w/wamount of protease, Savinase 16L (Novozymes, Denmark), was added to a commercial liquid detergent containing no enzymes. The composition of detergent is described in Table 2.
Culture supernatants of cellulases at 5% w/w were added to the detergent, and samples in plastic tubes with caps were incubated in a water bath at 50 C for minutes. The enzyme activity (NCU) was measured after incubation by the activity assay described in Example 1, except using longer reaction time of 30 minutes.
Results were calculated as residual activity CYO, which was obtained by dividing the activity of a sample after incubation at 50 C by the initial activity of the sample.
Table 2. Composition of commercial liquid detergent Ingredient %
Anionic surfactants 15 ¨ 30 Nonionic surfactants, soap 5¨ 15 Phosphonate, Soap <5 Boric acid Other ingredients: e.g. optical brighteners, perfumes, pH 8.2-8.6 Several variants showed improved stability of enzyme activity in commercial liquid detergent at 50 C compared to the parental MAO cellulase. Results 5 are shown in Table 3. Best stability was obtained with variants MA15, MA28 and especially MA79. Stability of variants MA15 and MA79 compared to MAO is shown in Figure 2 as residual activity. Both variants showed remarkably better stability than the parental cellulase.
io Table 3. Stability of MAO variants in detergent in the presence of protease (50 C, min). Symbol "+" indicates improved stability (measured as residual activity) compared to parental MAO cellulase, "+++++" indicates the best stability achieved in the test set.
Variant Stability MA1 ++
MA3 ++
MA9 ++
MA14 +
MA15 ++++
MA16 +++
MA26 +
MA28 ++++
MA29 +++
MA30 +
MA31 +
MA37 ++
MA46 +
MA53 +
MA54 +
MA56 +
MA61 ++
MA66 +++
MA71 ++
MA79 +++++
Example 3. Testing the antigreying performance of MAO variants in Launder-Ometer The most stable variant MA79 from Example 2 was tested for antigreying performance by a single wash method (40 C, 60 min, 16 dH) using carbon black (approx. 0.15 g/l) in a wash solution in addition to detergent (4.4 g/l).
Parental cellulase MAO was used as reference.
Cotton interlock double jersey with optical brighteners (CN-42) supplied from CFT
(Center for Testmaterials NV, the Netherlands) was used as test fabric. The fabric io was first prewashed in a washing machine (15 min 50 C and 60min at 60 C) and tumble dried, then cutted to swatches of approx. 14-14.5 cm (total weight of 4 swatches 25 g).
As a source of carbon black RD-liq 01 from CFT containing 7 g of carbon black liquid (about 33 (:)/0 carbon black) in plastic bottles, that are normally intended for full scale washes in washing machine (one bottle per one single wash with test fabrics), were used. In this Example the method was adapted to small scale using approximately similar ratio of carbon black and water that would be in full scale.
First a stock solution carbon black was prepared by placing an opened bottle of RD- liq 01 (i.e. about 2.3 g carbon black) in a decanter flask containing 1 liter of deionized water. The solution was stirred with a magnetic stirrer for overnight until the contents of the bottle were totally released. After that 65 g of stock solution mixed with 935 ml of synthetic tap water with hardness of 17.1 dH ending up to diluted carbon black solution having hardness of 16 dH and carbon black content approximately 0.15 g/I (or 0.45 g RD-liq 01).
For synthetic tap water with hardness of 17.1 dH the following stock solutions were prepared in deionized water (Milli-Q or equivalent):
Stock solution with 1000 d Calcium-hardness: CaCl2 x 2 H20 (1.02382.1000, Merck KGaA, Germany) 26.22 g/I
Stock solution with 200 d Magnesium-hardness: MgSO4 x 7 H20 (1.05886.1000, Merck KGaA, Germany) 8.79 g/I H20 NaHCO3 stock solution: NaHCO3 (1.06329.1000 Merck KGaA, Germany) 29.6 g/I.
made NaHCO3 solution were added in volumetric flask in the given order, made up to 1 liter with deionized water and mixed. The hardness of water was determined by complexometric titration and found correct.
Antigreying tests were performed in Atlas LP-2 Launder-Ometer as follows.
Launder-Ometer was first preheated to 40 C. 60 g of steel balls (diameter 0.6 cm), 1.1 g of commercial liquid detergent described in Example 2, 250 ml of diluted carbon black liquor and diluted enzyme (<1.0 ml) were added into 1.2 liter containers. After that, 4 swatches of prewashed test fabric CN-42 were added and lo the Launder-Ometer was run at 40 C for 60 min with a rotation speed of 42 rpm.
Enzymes were dosed 0, 0.25, 0.05, 0.1 and 0.2 activity units (NCU) per liter.
Activity was measured as described in Example 1.
After the cellulase treatment in Launder-Ometer, the swatches were first quickly rinsed separately under running tap water (ca. 20 C) to remove the steel balls, then rinsed separately under running water in specific cups containing holes for 3 times and finally dipped in a bucket containing water. After that the swatches were extracted in a washing machine and let to dry on a grid at room temperature.
Enzyme treated fabrics and controls without enzyme were rinsed and extracted separately to avoid contamination.
Antigreying performance of cellulase was evaluated by measuring reflectance of test fabrics by Konica Minolta CM3610A spectrophotometer as Y-value (illuminant D65/10 , 420 nm cut). Cellulase performance was calculated as AY (delta Y), which means value Y of enzyme treated fabric minus value Y of fabric treated with carbon black and detergent containing washing liquor without enzyme (enzyme blank, control). Values were the average of 4 swatches. The higher the Y or AY
value, the better the antigreying effect and whiteness of the fabric.
Results in Figure 3 show that the most stable variant MA79 had excellent antigreying properties similar to parental MAO cellulase in liquid detergent.
Also several other variants from Example 2, like MA1, MA3, MA15, MA29, had as good antigreying performance as MAO (data not shown).
Example 4. Long term stability of variant MA79 in liquid detergent measured as enzyme activity A cultivation sample of variant MA79 was tested for long term stability in a liquid detergent at 37 C, 30 C and room temperature (approx. 20 ¨ 22 C), using parental cellulase MAO as a reference. Tests were carried out with commercial liquid detergent described in Example 2 in the presence of added protease (0.8% w/w Savinase 16L). Cellulase preparations at 1(Yow/w were added to the detergent and samples in plastic tubes with caps were incubated at each temperature for several weeks or months. The enzyme activity was measured and results were calculated as residual activity as described in Example 2.
Results of tests obtained in commercial liquid detergent with protease are shown in Figures 4A-C. The long-term stability of variant MA79 was considerably improved compared to MAO at all temperatures, especially at 37 C.
Stability tests with variant MA79 and MAO were carried out also in a commercial l&I (Industrial & Institutional) detergent formulation containing protease and other enzymes except cellulase. A 0.5% w/w amount of cellulase preparation was added lo to the detergent and samples were incubated at 37 C for 6 weeks. Variant showed remarkably better stability than MAO also in this l&I detergent (Figure. 5).
Example 5. Long term stability of variant MA79 in liquid detergent measured as antigreying performance The stability of variant MA79 compared to the parental MAO cellulase was evaluated also as antigreying performance. Antigreying tests similar to that described in Example 3 were carried out with detergent samples stored for 88 and 193 days at 30 C. Cellulases were initially added to the detergent in such amount that dosage would be 0.2 activity units (NCU) per liter of wash solution.
Performance of stored samples was compared to washes, in which the enzymes had been added fresh into the washing liquor containing detergent and carbon black and results were calculated as relative performance indicating the residual performance level.
Results in Figure 6 show that variant MA79 had still excellent antigreying performance after storage of over 6 months at elevated temperature like 30 C.
The performance of MAO was considerably reduced compared to MA79 already after 12 weeks.
Example 6. Stability of variant MA79 in liquid detergents compared to commercial cellulases A production like sample was prepared from pilot scale fermentation sample of MA79 and retested for stability in liquid detergents at various temperatures for 6 weeks, using preparation of parental cellulase MAO and/or commercial cellulase Celluclean 5000L (Novozymes, Denmark) for comparison.
Tests were carried out in commercial liquid detergent (described in Table2/Example 2) in the presence of added protease like described in Example 4. Also a concentrated liquid detergent containing protease and other enzymes except cellulase was tested. Cellulases at 0.5% w/w were added to the detergents.
Based on results shown in Figure 7 variant MA79 had considerably better stability compared to Celluclean 5000L in commercial liquid detergent at 37 C. Results obtained with another detergent, liquid detergent concentrate show that variant MA79 had significantly better stability than both MAO and Celluclean 5000L at (Figure 8A). In this detergent the stability of MA79 was better than Celluclean 5000L also at 30 C (Figure 8B) and at room temperature approx. 20-22 C (data not shown).
Example 7. Screening of MAO variants MA80-MA116 based on their stability in commercial liquid detergent at 50 C
Stability of MAO variants MA80 - MA116 produced in Trichoderma as described in Example 1 was tested in a commercial liquid detergent in the presence of protease at 50 C as described in Example 2 Parental cellulase MAO and stable variant were used as references.
Several variants showed improved stability in commercial liquid detergent compared to the parental MAO cellulase, when incubation time of 30 min at 50 C
was used. For differentiating variants having higher stability than the most stable variant MA79 from Example 2, the incubation time had to be increased to 24 hours.
Thermal incubator was used instead of water bath. Residual activities of the best variants after 24 h incubation at 50 C are shown in Figure 9. Especially variants MA88 and MA93 had improved stability compared to MA79. Parental molecule MAO had practically no activity left after 24 h. Variants MA88, MA93 and MA103 showed also excellent antigreying properties, at least as good as parental molecule MO, when tested like described in Example 3 (data not shown).
REFERENCES
Bailey M and Nevalainen H. 1981. Induction, isolation and testing of stable Trichoderma reesei mutants with improved production of solubilizing cellulase. Enzyme Microb.
Technol. 3:153-157.
Haakana H, Miettinen-Oinonen A, Joutsjoki V, Mantyla A, Suominen P and Vehmaanpera J. 2004. Cloning of cellulase genes from Melanocarpus albomyces and their efficient expression in Trichoderma reesei. Enzyme Microb. Technol. 34:159-167.
Henrissat B. 1991. A classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem. J. 280:309-316.
Henrissat B and Bairoch A. 1993. New families in the classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem. J. 293:781-788.
Henrissat B and Bairoch A. 1996. Updating the sequence-based classification of glycosyl hydrolases. Biochem. J. 316:695-696.
Joutsjoki VV, TK Torkkeli and KMH Nevalainen. 1993. Transformation of Trichoderma reesei with the Hormoconis resinae glucoamylase P (gamP) gene: production of a heterologous glucoamylase by Trichoderma reesei. Curr. Genet. 24:223-228.
Karhunen T, A Mantyla, KMH Nevalainen and PL Suominen. 1993. High frequency one-5 step gene replacement in Trichoderma reesei. I. Endoglucanase I
overproduction. Mol.
Gen. Genet. 241:515-522.
Paloheimo M, A Mantyla, J Kallio, and P Suominen. 2003. High-yield production of a bacterial xylanase in the filamentous fungus Trichoderma reesei requires a carrier polypeptide with an intact domain structure. Appl. Env. Microbiol. 69:7073-7082.
10 Penttila M, H Nevalainen, M Rano, E Salminen and J Knowles. 1987. A
versatile transformation system for the cellulolytic filamentous fungus Trichoderma reesei. Gene 61:155-164.
Sambrook J and DW Russell. 2001. Molecular cloning, a laboratory manual. Cold Spring Harbor Laboratory, New York, US.
The variant cellulase polypeptides and enzyme compositions containing them may be used in biostoning of denim. As used in the present context, the expression "biostoning" of fabric or garment means the use of enzymes in place of, or in 15 addition to, pumice stones for the treatment of fabric or garment, especially denim to obtain an aged or worn look. The term "aged or worn look" means that as a result of uneven dye removal, there are contrasts between dyed areas and areas from which dye has been removed.
The liquor ratio (the ratio of the volume of liquid per weight of fabric) in both biostoning and biofinishing may range from about 3:1 to 20:1, preferably 5:1 to 10:1. The treatment time can vary between 15 min to 90 min and preferably between 30 min to 60 min. It should be emphasized that the enzyme dosage greatly depends on the type of the fabrics, machinery, process conditions (pH, temperature, liquor ratio, treatment time, denim load, process scale) and type of the enzyme preparation or composition. Typical process parameters for e.g.
industrial biofinishing are pH 4.5 - 8 at temperature of 40 - 65 C. A person skilled in art is capable in defining suitable dosages and conditions.
SEQUENCE LISTING
SEQ ID NO:1 The full-length amino acid sequence of MAO cellulase deriving from the Melanocarpus albomyces ALK04237 GH45 20K-cellulase including amino acids from Met1 to Ala235.
SEQ ID NO:2 The nucleotide sequence of the full-length MAO cellulase deriving from Melanocarpus albomyces ALK04237 ce145 20K-cellulase.
SEQ ID NO:3 The amino acid sequence of the mature MAO cellulase deriving from the Melanocarpus albomyces ALK04237 GH45 20K-cellulase including amino acids from Alai to Ala214.
DEPOSITS
Melanocarpus albomyces ALK04237 was deposited at the Centraalbureau Voor Schimmelcultures at Upsalalaan 8, 3584 CT, Utrecht, The Netherlands on 2 March 2012 and assigned accession number CBS132099.
EXAMPLES
Standard molecular biology methods were used in the isolation and enzyme treatments of DNA (e.g. isolation of plasmid DNA, digestion of DNA to produce DNA fragments), in E. coli transformations, sequencing etc. The basic laboratory methods used were either as described by the enzyme, reagent or kit manufacturer or as described in the standard molecular biology handbooks, e.g. Sambrook and Russell (2001) or as described in the following examples.
Example 1. Production of Melanocarpus albomyces MAO variants in Trichoderma reesei Melanocarpus albomyces ce/45 20K-cellulase variants were derived from a parental molecule, designated here as MAO (nucleic acid sequence SEQ ID NO:
2, corresponding to amino acid sequence SEQ ID NO: 1). Expression plasmids were constructed for production of recombinant ce/45 MAO variants (Figure 1).
The constructs contain T. reesei cei7A promoter and terminator and the amdS marker gene as described in Paloheimo et al. 2003. The variant genes contain a signal sequence at position 1-63 nt and intron sequences at positions 84-154 nt and 473 nt. Synthetic genes, including mutations introduced in the core region of the parental molecule (Table 1), were exactly fused as SacII-BamH1 fragments to the T. reesei ce/7A promoter by ligation. For construction of the expression plasmid for MA79 variant a 328 bp Sall - BamHI fragment of pALK4472 was isolated and ligated into a 8523 bp Sall - BamHI fragment of pALK4458. Expression plasm ids are listed in Table 1.
Table 1. The synthetic genes used in construction of the expression cassettes for production of MAO cellulase variants in T. reesei. Amino acid positions are numbered by correspondence with the mature amino acid sequence without signal sequence (SEQ ID NO: 3).
Gene/ variant Expression Mutation designation plasmid MA1 G22A pALK4458 MA2 P23R pALK4459 MA3 F35W pALK4460 MA4 F35D pALK4461 MA5 H39S pALK4462 MA6 H39P pALK4463 MA7 A43S pALK4464 MA8 V44R, E48D pALK4465 MA9 V44Q pALK4466 MA10 F53Y pALK4467 MA11 A62S pALK4468 MA13 E82S pALK4470 MA14 A99Q pALK4471 MA15 N122A pALK4472 MA16 N122L pALK4473 MA17 L130G pALK4474 MA18 P136S pALK4475 MA19 S151D pALK4476 MA20 Q153S pALK4477 MA21 D156S pALK4478 MA22 P161S pALK4479 MA24 V193T pALK4481 MA25 V193D pALK4482 MA26 A194Q pALK4483 MA27 F206Y pALK4484 MA28 S54M, N122A pALK4485 MA29 G22A, E82S pALK4486 MA30 F35W, H39P pALK4487 MA31 H39S, V44Q pALK4488 MA32 A43S, F53Y pALK4489 MA35 F53T, P136S pALK4492 MA37 V44R, E48D, G22A, E82S pALK4494 MA40 A19D pALK4497 MA41 K21E pALK4498 MA42 K21Q pALK4499 MA43 G2OR pALK4209 MA44 S3OL pALK4210 MA45 S3OP pALK4211 MA46 A33R pALK4212 MA47 F35M pALK4213 MA48 Q36R pALK4214 MA49 V44 L pALK4215 MA50 E481 pALK4216 MA52 A75S pALK4218 MA53 A75H pALK4219 MA54 T92I pALK4220 MA55 T94 R pALK4221 MA56 T1081 pALK4222 MA57 F131I pALK4223 MA59 Q174H pALK4225 MA60 N175D pALK4226 MA61 D177Q pALK4227 MA62 Vi 931 pALK4228 MA63 A194S pALK4229 MA64 G205R pALK4230 MA65 A207R pALK4231 MA66 A207S pALK4232 MA67 A33L pALK4233 MA68 Q36H pALK4234 MA69 V44L, E481 pALK4235 MA70 A33L, F35M, Q36R pALK4236 MA71 N175D, D177Q pALK4237 MA72 T92I, T94R pALK4238 MA73 G205R, A207S pALK4239 MA74 P1240, G1650 pALK4240 MA75 S5C, F119C, V1051 pALK4241 MA76 F350, A560 pALK4242 MA77 S680, M1030, V1051 pALK4243 MA78 V1860, A2070 pALK4244 MA79 G22A, N122A pALK4621 MA80 N122S pALK4718 MA81 N122G pALK4719 MA82 N122T pALK4720 MA83 N122V pALK4721 MA84 N122I pALK4722 MA85 G22S pALK4723 MA86 G22V pALK4724 MA87 G22A, S54A, N122A pALK4725 MA88 G22A, S54T, N122A pALK4726 MA89 G22A, S54L, N122A pALK4727 MA90 G22A, S54V, N122A pALK4728 MA91 G22A, E82R, N122A pALK4729 MA92 G22A, E82W, N122A pALK4730 MA93 G22A, T1081, N122A pALK4731 MA94 G22A, V44R, N122A pALK4732 MA95 G22A, V44W, N122A pALK4733 MA96 G22A, V44L, N122A pALK4734 MA97 G22A, A75S, N122A pALK4735 MA98 G22A, A75R, N122A pALK4736 MA99 G22A, F35M, N122A pALK4737 MA100 N2W, G22A, N122A pALK4738 MA101 N2R, G22A, N122A pALK4739 MA102 G22A, N122A, Q174R pALK4740 MA103 G22A, N122A, G205T pALK4741 MA104 G22A, F35W, A75H, T1081, N122A, A207S pALK4742 MA107 G22A, N122A, Q174R, D177E pALK4745 MA109 G22A, N122A, F206H pALK4748 MA110 G22A, N122A, del(A207-A214) pALK4749 MA111 G22A, N122A, del(V208-A214) pALK4750 MA112 G22A, N122A, del(F209-A214) pALK4751 MA113 G22A, N122A, del(K210-A214) pALK4752 MA114 G22A, N122A, del(A211-A214) pALK4753 MA115 G22A, N122A, del(P212-A214) pALK4754 MA116 G22A, N122A, del(S213-A214) pALK4755 The linear expression cassette was isolated from the vector backbone by EcoRI
digestion or the circular plasmid was used directly in T. reesei protoplast transformation. The transformants were selected with acetamide as the sole nitrogen source. The host strain lacks the four major endogenous cellulases:
CBHI/Cel7A, CBHII/Cel6A, EGI/Cel7B and EGII/Cel5A. The transformations were performed according to Penttila et al, 1987, with the modifications described in Karhunen et al., 1993. The transformants were purified on selection plates through single conidia prior to sporulating them on potato dextrose agar.
The cellulase production of the transformants was analyzed from the culture supernatants of shake flask cultivations (50 ml). The transformants were grown for 7 days at 3000, 250 rpm in a complex cellulase-inducing medium (Joutsjoki et al., 1993) buffered with 5% KH2PO4 at pH 5.5. The enzyme activity of the recombinant protein was measured from the culture supernatant as the release of reducing sugars from carboxymethylcellulose (3% CMC) at 50 C in 50 mM HEPES buffer pH 7.0 essentially as described by Bailey and Nevalainen, 1981; Haakana, et al, 2004 (NCU activity). Production of the recombinant protein was also detected from the culture supernatant by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Chosen transformants and the reference strain producing the parental MAO
cellulase were cultivated in shake flasks or bioreactors in complex cellulase-inducing medium to obtain material for the application tests (Examples 2 to 6).
Example 2. Screening of MAO variants MAl-MA79 based on their stability in commercial liquid detergent at 50 C
MAO variants produced in Trichoderma as described in Example 1 were screened based on detergent stability at 50 C by a rapid test in the presence of protease.
Parental cellulase MAO was used as reference. A 0.8% w/wamount of protease, Savinase 16L (Novozymes, Denmark), was added to a commercial liquid detergent containing no enzymes. The composition of detergent is described in Table 2.
Culture supernatants of cellulases at 5% w/w were added to the detergent, and samples in plastic tubes with caps were incubated in a water bath at 50 C for minutes. The enzyme activity (NCU) was measured after incubation by the activity assay described in Example 1, except using longer reaction time of 30 minutes.
Results were calculated as residual activity CYO, which was obtained by dividing the activity of a sample after incubation at 50 C by the initial activity of the sample.
Table 2. Composition of commercial liquid detergent Ingredient %
Anionic surfactants 15 ¨ 30 Nonionic surfactants, soap 5¨ 15 Phosphonate, Soap <5 Boric acid Other ingredients: e.g. optical brighteners, perfumes, pH 8.2-8.6 Several variants showed improved stability of enzyme activity in commercial liquid detergent at 50 C compared to the parental MAO cellulase. Results 5 are shown in Table 3. Best stability was obtained with variants MA15, MA28 and especially MA79. Stability of variants MA15 and MA79 compared to MAO is shown in Figure 2 as residual activity. Both variants showed remarkably better stability than the parental cellulase.
io Table 3. Stability of MAO variants in detergent in the presence of protease (50 C, min). Symbol "+" indicates improved stability (measured as residual activity) compared to parental MAO cellulase, "+++++" indicates the best stability achieved in the test set.
Variant Stability MA1 ++
MA3 ++
MA9 ++
MA14 +
MA15 ++++
MA16 +++
MA26 +
MA28 ++++
MA29 +++
MA30 +
MA31 +
MA37 ++
MA46 +
MA53 +
MA54 +
MA56 +
MA61 ++
MA66 +++
MA71 ++
MA79 +++++
Example 3. Testing the antigreying performance of MAO variants in Launder-Ometer The most stable variant MA79 from Example 2 was tested for antigreying performance by a single wash method (40 C, 60 min, 16 dH) using carbon black (approx. 0.15 g/l) in a wash solution in addition to detergent (4.4 g/l).
Parental cellulase MAO was used as reference.
Cotton interlock double jersey with optical brighteners (CN-42) supplied from CFT
(Center for Testmaterials NV, the Netherlands) was used as test fabric. The fabric io was first prewashed in a washing machine (15 min 50 C and 60min at 60 C) and tumble dried, then cutted to swatches of approx. 14-14.5 cm (total weight of 4 swatches 25 g).
As a source of carbon black RD-liq 01 from CFT containing 7 g of carbon black liquid (about 33 (:)/0 carbon black) in plastic bottles, that are normally intended for full scale washes in washing machine (one bottle per one single wash with test fabrics), were used. In this Example the method was adapted to small scale using approximately similar ratio of carbon black and water that would be in full scale.
First a stock solution carbon black was prepared by placing an opened bottle of RD- liq 01 (i.e. about 2.3 g carbon black) in a decanter flask containing 1 liter of deionized water. The solution was stirred with a magnetic stirrer for overnight until the contents of the bottle were totally released. After that 65 g of stock solution mixed with 935 ml of synthetic tap water with hardness of 17.1 dH ending up to diluted carbon black solution having hardness of 16 dH and carbon black content approximately 0.15 g/I (or 0.45 g RD-liq 01).
For synthetic tap water with hardness of 17.1 dH the following stock solutions were prepared in deionized water (Milli-Q or equivalent):
Stock solution with 1000 d Calcium-hardness: CaCl2 x 2 H20 (1.02382.1000, Merck KGaA, Germany) 26.22 g/I
Stock solution with 200 d Magnesium-hardness: MgSO4 x 7 H20 (1.05886.1000, Merck KGaA, Germany) 8.79 g/I H20 NaHCO3 stock solution: NaHCO3 (1.06329.1000 Merck KGaA, Germany) 29.6 g/I.
made NaHCO3 solution were added in volumetric flask in the given order, made up to 1 liter with deionized water and mixed. The hardness of water was determined by complexometric titration and found correct.
Antigreying tests were performed in Atlas LP-2 Launder-Ometer as follows.
Launder-Ometer was first preheated to 40 C. 60 g of steel balls (diameter 0.6 cm), 1.1 g of commercial liquid detergent described in Example 2, 250 ml of diluted carbon black liquor and diluted enzyme (<1.0 ml) were added into 1.2 liter containers. After that, 4 swatches of prewashed test fabric CN-42 were added and lo the Launder-Ometer was run at 40 C for 60 min with a rotation speed of 42 rpm.
Enzymes were dosed 0, 0.25, 0.05, 0.1 and 0.2 activity units (NCU) per liter.
Activity was measured as described in Example 1.
After the cellulase treatment in Launder-Ometer, the swatches were first quickly rinsed separately under running tap water (ca. 20 C) to remove the steel balls, then rinsed separately under running water in specific cups containing holes for 3 times and finally dipped in a bucket containing water. After that the swatches were extracted in a washing machine and let to dry on a grid at room temperature.
Enzyme treated fabrics and controls without enzyme were rinsed and extracted separately to avoid contamination.
Antigreying performance of cellulase was evaluated by measuring reflectance of test fabrics by Konica Minolta CM3610A spectrophotometer as Y-value (illuminant D65/10 , 420 nm cut). Cellulase performance was calculated as AY (delta Y), which means value Y of enzyme treated fabric minus value Y of fabric treated with carbon black and detergent containing washing liquor without enzyme (enzyme blank, control). Values were the average of 4 swatches. The higher the Y or AY
value, the better the antigreying effect and whiteness of the fabric.
Results in Figure 3 show that the most stable variant MA79 had excellent antigreying properties similar to parental MAO cellulase in liquid detergent.
Also several other variants from Example 2, like MA1, MA3, MA15, MA29, had as good antigreying performance as MAO (data not shown).
Example 4. Long term stability of variant MA79 in liquid detergent measured as enzyme activity A cultivation sample of variant MA79 was tested for long term stability in a liquid detergent at 37 C, 30 C and room temperature (approx. 20 ¨ 22 C), using parental cellulase MAO as a reference. Tests were carried out with commercial liquid detergent described in Example 2 in the presence of added protease (0.8% w/w Savinase 16L). Cellulase preparations at 1(Yow/w were added to the detergent and samples in plastic tubes with caps were incubated at each temperature for several weeks or months. The enzyme activity was measured and results were calculated as residual activity as described in Example 2.
Results of tests obtained in commercial liquid detergent with protease are shown in Figures 4A-C. The long-term stability of variant MA79 was considerably improved compared to MAO at all temperatures, especially at 37 C.
Stability tests with variant MA79 and MAO were carried out also in a commercial l&I (Industrial & Institutional) detergent formulation containing protease and other enzymes except cellulase. A 0.5% w/w amount of cellulase preparation was added lo to the detergent and samples were incubated at 37 C for 6 weeks. Variant showed remarkably better stability than MAO also in this l&I detergent (Figure. 5).
Example 5. Long term stability of variant MA79 in liquid detergent measured as antigreying performance The stability of variant MA79 compared to the parental MAO cellulase was evaluated also as antigreying performance. Antigreying tests similar to that described in Example 3 were carried out with detergent samples stored for 88 and 193 days at 30 C. Cellulases were initially added to the detergent in such amount that dosage would be 0.2 activity units (NCU) per liter of wash solution.
Performance of stored samples was compared to washes, in which the enzymes had been added fresh into the washing liquor containing detergent and carbon black and results were calculated as relative performance indicating the residual performance level.
Results in Figure 6 show that variant MA79 had still excellent antigreying performance after storage of over 6 months at elevated temperature like 30 C.
The performance of MAO was considerably reduced compared to MA79 already after 12 weeks.
Example 6. Stability of variant MA79 in liquid detergents compared to commercial cellulases A production like sample was prepared from pilot scale fermentation sample of MA79 and retested for stability in liquid detergents at various temperatures for 6 weeks, using preparation of parental cellulase MAO and/or commercial cellulase Celluclean 5000L (Novozymes, Denmark) for comparison.
Tests were carried out in commercial liquid detergent (described in Table2/Example 2) in the presence of added protease like described in Example 4. Also a concentrated liquid detergent containing protease and other enzymes except cellulase was tested. Cellulases at 0.5% w/w were added to the detergents.
Based on results shown in Figure 7 variant MA79 had considerably better stability compared to Celluclean 5000L in commercial liquid detergent at 37 C. Results obtained with another detergent, liquid detergent concentrate show that variant MA79 had significantly better stability than both MAO and Celluclean 5000L at (Figure 8A). In this detergent the stability of MA79 was better than Celluclean 5000L also at 30 C (Figure 8B) and at room temperature approx. 20-22 C (data not shown).
Example 7. Screening of MAO variants MA80-MA116 based on their stability in commercial liquid detergent at 50 C
Stability of MAO variants MA80 - MA116 produced in Trichoderma as described in Example 1 was tested in a commercial liquid detergent in the presence of protease at 50 C as described in Example 2 Parental cellulase MAO and stable variant were used as references.
Several variants showed improved stability in commercial liquid detergent compared to the parental MAO cellulase, when incubation time of 30 min at 50 C
was used. For differentiating variants having higher stability than the most stable variant MA79 from Example 2, the incubation time had to be increased to 24 hours.
Thermal incubator was used instead of water bath. Residual activities of the best variants after 24 h incubation at 50 C are shown in Figure 9. Especially variants MA88 and MA93 had improved stability compared to MA79. Parental molecule MAO had practically no activity left after 24 h. Variants MA88, MA93 and MA103 showed also excellent antigreying properties, at least as good as parental molecule MO, when tested like described in Example 3 (data not shown).
REFERENCES
Bailey M and Nevalainen H. 1981. Induction, isolation and testing of stable Trichoderma reesei mutants with improved production of solubilizing cellulase. Enzyme Microb.
Technol. 3:153-157.
Haakana H, Miettinen-Oinonen A, Joutsjoki V, Mantyla A, Suominen P and Vehmaanpera J. 2004. Cloning of cellulase genes from Melanocarpus albomyces and their efficient expression in Trichoderma reesei. Enzyme Microb. Technol. 34:159-167.
Henrissat B. 1991. A classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem. J. 280:309-316.
Henrissat B and Bairoch A. 1993. New families in the classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem. J. 293:781-788.
Henrissat B and Bairoch A. 1996. Updating the sequence-based classification of glycosyl hydrolases. Biochem. J. 316:695-696.
Joutsjoki VV, TK Torkkeli and KMH Nevalainen. 1993. Transformation of Trichoderma reesei with the Hormoconis resinae glucoamylase P (gamP) gene: production of a heterologous glucoamylase by Trichoderma reesei. Curr. Genet. 24:223-228.
Karhunen T, A Mantyla, KMH Nevalainen and PL Suominen. 1993. High frequency one-5 step gene replacement in Trichoderma reesei. I. Endoglucanase I
overproduction. Mol.
Gen. Genet. 241:515-522.
Paloheimo M, A Mantyla, J Kallio, and P Suominen. 2003. High-yield production of a bacterial xylanase in the filamentous fungus Trichoderma reesei requires a carrier polypeptide with an intact domain structure. Appl. Env. Microbiol. 69:7073-7082.
10 Penttila M, H Nevalainen, M Rano, E Salminen and J Knowles. 1987. A
versatile transformation system for the cellulolytic filamentous fungus Trichoderma reesei. Gene 61:155-164.
Sambrook J and DW Russell. 2001. Molecular cloning, a laboratory manual. Cold Spring Harbor Laboratory, New York, US.
Claims (24)
1. A cellulase variant polypeptide, or an active fragment thereof, characterized in that the variant polypeptide has cellulase activity and comprises an amino acid sequence having at least 90% identity to residues 22-235 of SEQ ID NO:1 comprising a substitution or deletion at one or more position selected from:
22, 122, 2, 33, 35, 39, 44, 48, 54, 75, 82, 92, 99, 108, 174, 175, 177, 194, 205, 206, 207, 208, 209, 210, 211, 212, 213 and 214, wherein the amino acid positions of said variant polypeptide or active fragment thereof are numbered by correspondence with the mature amino acid sequence of SEQ ID NO:3.
22, 122, 2, 33, 35, 39, 44, 48, 54, 75, 82, 92, 99, 108, 174, 175, 177, 194, 205, 206, 207, 208, 209, 210, 211, 212, 213 and 214, wherein the amino acid positions of said variant polypeptide or active fragment thereof are numbered by correspondence with the mature amino acid sequence of SEQ ID NO:3.
2. The cellulase variant polypeptide of claim 1, characterized in that the polypeptide comprises one or more of the following substitutions or deletions: N2W, N2R, G22A, G225, G22V, A33R, F35W, F35M, H39P, H395, V44R, V44Q, V44W, V44L, E48D, S54M, S54A, S54T, S54L, S54V A75H, A7S5, A75R, E825, E82R, E82W, T92I, A99Q, T1081, N122A, N122L, N1225, N122G, N122T, N122V, N1221, Q174R, N175D, D177Q, D177E, A194Q, G205T, F206H, A207R, A2075, del(A207-A214), del(V208-A214), del(F209-A214), del(K210-A214), del(A211-A214), del(P212- A214) and del(5213-A214).
3. The cellulase variant polypeptide of claim 1 or 2, characterized in that the variant comprises a substitution at positions 22 and/or 122, wherein at position 22 G
is substituted to A, S or V and at position 122 N is substituted to A, S, G, T, V
or I.
is substituted to A, S or V and at position 122 N is substituted to A, S, G, T, V
or I.
4. The cellulase variant polypeptide of claim 3, characterized in that the variant comprises a substitution at positions 22 and 122 and at least one further substitution or deletion.
5. The cellulase variant polypeptide of claim 4, characterized in that the further substitution is selected from the substitutions at position 2, 35, 44, 54, 75, 82, 108, 174, 177, 205, 206 or 207.
6. The cellulase variant polypeptide of claim 4, characterized in that the further deletion is selected from the following: del(A207-A214), del(V208- A214), del(F209-A214), del(K210-A214), del(A211-A214), del(P212-A214) or del(S213-A214).
7. An isolated nucleic acid molecule comprising a nucleotide sequence which encodes the cellulase variant polypeptide according to any of claims 1 to 6.
8. The isolated nucleic acid molecule according to claim 7, characterized in that the nucleic acid molecule comprises a nucleotide sequence defined in SEQ ID
NO: 2.
NO: 2.
9. A recombinant expression vector comprising a nucleotide sequence encoding the cellulase variant polypeptide according to any of claims 1 to 6 operably linked to regulatory sequences capable of directing expression of the gene encoding said cellulase variant in a suitable host.
10. A host cell comprising the recombinant expression vector according to claim 9.
11. The host cell according to claim 10, characterized in that said host is selected from the group consisting of:
fungal cells, filamentous fungal cells from Division Ascomycota, Subdivision Pezizomycotina; preferably from the group consisting of members of the Class Sordariomycetes, Subclass Hypocreomycetidae, Orders Hypocreales and Microascales and Aspergillus, Chrysosporium, Myceliophthora and Humicola;
more preferably from the group consisting of Families Hypocreacea, Nectriaceae, Clavicipitaceae, Microascaceae, and Genera Trichoderma (anamorph of Hypocrea), Fusarium, Gibberella, Nectria, Stachybotrys, Claviceps, Metarhizium, Villosiclava, Ophiocordyceps, Cephalosporium, and Scedosporium;
more preferably from the group consisting of Trichoderma reesei (Hypocrea jecorina), T. citrinoviridae, T. longibrachiatum, T. virens, T. harzianum, T.
asperellum, T. atroviridae, T. parareesei, Fusarium oxysporum, F.
gramineanum, F. pseudograminearum, F. venenatum, Gibberella fujikuroi, G.
moniliformis, G. zeaea, Nectria (Haematonectria) haematococca, Stachybotrys chartarum, S. chlorohalonata, Claviceps purpurea, Metarhizium acridum, M. anisopliae, Villosiclava virens, Ophiocordyceps sinensis, Acremonium (Cephalosporium) chrysogenum, and Scedosporium apiospermum, and Aspergillus niger, Aspergillus awamori, Aspergillus oryzae, Chrysosporium lucknowense, Myceliophthora thermophila, Humicola insolens, and Humicola grisea, bacterial cells, preferably gram-positive Bacilli such as B. subtilis, B.
licheniformis, B. megaterium, B. amyloliquefaciens, B. pumilus, gram negative bacteria such as Escherichia coli, actinomycetales such as Streptomyces sp., and yeasts, such as Saccharomyces cerevisiae, Pichia pastoris, Yarrowia lipolytica, most preferably Trichoderma reesei or Bacillus.
fungal cells, filamentous fungal cells from Division Ascomycota, Subdivision Pezizomycotina; preferably from the group consisting of members of the Class Sordariomycetes, Subclass Hypocreomycetidae, Orders Hypocreales and Microascales and Aspergillus, Chrysosporium, Myceliophthora and Humicola;
more preferably from the group consisting of Families Hypocreacea, Nectriaceae, Clavicipitaceae, Microascaceae, and Genera Trichoderma (anamorph of Hypocrea), Fusarium, Gibberella, Nectria, Stachybotrys, Claviceps, Metarhizium, Villosiclava, Ophiocordyceps, Cephalosporium, and Scedosporium;
more preferably from the group consisting of Trichoderma reesei (Hypocrea jecorina), T. citrinoviridae, T. longibrachiatum, T. virens, T. harzianum, T.
asperellum, T. atroviridae, T. parareesei, Fusarium oxysporum, F.
gramineanum, F. pseudograminearum, F. venenatum, Gibberella fujikuroi, G.
moniliformis, G. zeaea, Nectria (Haematonectria) haematococca, Stachybotrys chartarum, S. chlorohalonata, Claviceps purpurea, Metarhizium acridum, M. anisopliae, Villosiclava virens, Ophiocordyceps sinensis, Acremonium (Cephalosporium) chrysogenum, and Scedosporium apiospermum, and Aspergillus niger, Aspergillus awamori, Aspergillus oryzae, Chrysosporium lucknowense, Myceliophthora thermophila, Humicola insolens, and Humicola grisea, bacterial cells, preferably gram-positive Bacilli such as B. subtilis, B.
licheniformis, B. megaterium, B. amyloliquefaciens, B. pumilus, gram negative bacteria such as Escherichia coli, actinomycetales such as Streptomyces sp., and yeasts, such as Saccharomyces cerevisiae, Pichia pastoris, Yarrowia lipolytica, most preferably Trichoderma reesei or Bacillus.
12. A process of producing a cellulase variant polypeptide according to any of claims 1 to 6, said process comprising the steps of culturing the host cell according to any of claims 9 to 10 and recovering the polypeptide.
13. A process for obtaining an enzyme composition, which comprises the cellulase variant polypeptide according to any of claims 1 to 5, said process comprising the steps of culturing a host cell according to any of claims 10 to 11 and either recovering the polypeptide from the cells or separating the cells from the culture medium and obtaining the whole culture broth.
14. An enzyme composition comprising the cellulase variant polypeptide according to any of claims 1 to 6.
15. The enzyme composition according to claim 14, characterized in that said composition further comprises other enzymes selected from the group of proteases, amylases, cellulases, lipases, xylanases, mannanases, cutinases, esterases, phytases, DNAses, pectinases, pectate lyases, pectinolytic enzymes, carbohydrases, arabinases, galactanases, xanthanases, xyloglucanases, laccases, peroxidases and oxidases with or without a mediator.
16. The enzyme composition according to claim 14 or 15, characterized in that said composition comprises a suitable additive selected from the group of stabilizers, buffers, surfactants, builders, bleaching agents, mediators, anti-corrosion agents, antiredeposition agents, caustics, abrasives, optical brighteners, dyes, pigments, and preservatives.
17. The enzyme composition according to any one of claims 14 to 16, characterized in that said enzyme composition is in the form of liquid composition or a solid composition such as solution, dispersion, paste, powder, granule, granulate, coated granulate, tablet, cake, crystal, crystal slurry, gel, or pellet.
18. The cellulase variant polypeptide according to any of claims 1 to 6 or the enzyme composition according to any of claims 14 to 17 for use in detergents, in treating fiber, in wood-derived pulp, in biomass hydrolysis, in food or feed application, or in any application involving modification, degradation or removal of cellulose containing material.
19. A method for antigreying, stain removal, fiber and color care, biostoning or biofinishing which comprises a step of adding the cellulase variant polypeptide according to any of claims 1 to 6 or the enzyme preparation according to any of claims 14 to 17 to liquid used in treating cotton containing fabric or garments or other textile materials like fabrics or garments or yarn.
20. The method of claim 19, wherein the textile materials are manufactured of natural cellulose containing fibers or manmade cellulose containing fibers or are mixtures thereof.
21. A detergent composition, characterized in that it comprises the cellulase variant polypeptide according to any of claims 1 to 6 or the enzyme composition according to any of claims 14 to 17.
22. The detergent composition of claim 21 in the form of liquid detergent or a solid detergent, preferably in the form of a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid.
23. The detergent composition according to claim 21 or 22, characterized in that said composition comprises one or more additional enzymes selected from the group of proteases, amylases, cellulases, lipases, xylanases, mannanases, cutinases, esterases, DNAses, pectinases, pectate lyases, pectinolytic enzymes, carbohydrases, arabinases, galactanases, xanthanases, xyloglucanases, laccases, peroxidases and oxidases, preferably from the group of proteases, amylases, cellulases and lipases.
24. A method of treating cellulosic fiber containing textile material, wherein said method comprises contacting said textile material with the detergent composition according to any of claims 21 to 23.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17209301.5 | 2017-12-21 | ||
US15/850,712 US10570383B2 (en) | 2017-12-21 | 2017-12-21 | Variants of fungal cellulase |
EP17209301.5A EP3502243A1 (en) | 2017-12-21 | 2017-12-21 | Variants of fungal cellulase |
US15/850,712 | 2017-12-21 | ||
PCT/FI2018/050935 WO2019122520A1 (en) | 2017-12-21 | 2018-12-17 | Variants of fungal cellulase |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3084907A1 true CA3084907A1 (en) | 2019-06-27 |
Family
ID=66992532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3084907A Pending CA3084907A1 (en) | 2017-12-21 | 2018-12-17 | Variants of fungal cellulase |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3728579A4 (en) |
KR (1) | KR102413168B1 (en) |
CN (1) | CN111670250B (en) |
BR (1) | BR112020011352A2 (en) |
CA (1) | CA3084907A1 (en) |
WO (1) | WO2019122520A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109234174B (en) * | 2018-11-12 | 2021-04-27 | 陕西科技大学 | Thermophilic fungus for producing cellulase and application thereof |
DE102022205588A1 (en) | 2022-06-01 | 2023-12-07 | Henkel Ag & Co. Kgaa | DETERGENT AND CLEANING AGENTS WITH IMPROVED ENZYME STABILITY |
DE102022205593A1 (en) | 2022-06-01 | 2023-12-07 | Henkel Ag & Co. Kgaa | DETERGENT AND CLEANING AGENTS WITH IMPROVED ENZYME STABILITY |
DE102022205594A1 (en) | 2022-06-01 | 2023-12-07 | Henkel Ag & Co. Kgaa | PERFORMANCE-IMPROVED AND STORAGE-STABLE PROTEASE VARIANTS |
DE102022205591A1 (en) | 2022-06-01 | 2023-12-07 | Henkel Ag & Co. Kgaa | DETERGENT AND CLEANING AGENTS WITH IMPROVED ENZYME STABILITY |
EP4324900A1 (en) | 2022-08-17 | 2024-02-21 | Henkel AG & Co. KGaA | Detergent composition comprising enzymes |
DE102022211482A1 (en) | 2022-10-28 | 2024-05-08 | Henkel Ag & Co. Kgaa | Natural dye coloring with improved color intensity |
DE102022211856A1 (en) | 2022-11-09 | 2024-05-16 | Henkel Ag & Co. Kgaa | Two-stage dyeing process with natural dyes with improved color intensity |
DE102022131732A1 (en) | 2022-11-30 | 2024-06-06 | Henkel Ag & Co. Kgaa | Improved washing performance through the use of a protease fused with a special adhesion promoter peptide |
DE102023200106A1 (en) | 2023-01-10 | 2024-07-11 | Henkel Ag & Co. Kgaa | ENZYME-CONTAINING WASHING AND CLEANING AGENTS |
CN117384891B (en) * | 2023-12-13 | 2024-03-15 | 北京科为博生物科技有限公司 | Acidic xylanase with improved thermal stability, and gene and application thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7299796A (en) * | 1995-10-17 | 1997-05-07 | Rohn Enzyme Finland Oy | Cellulases, the genes encoding them and uses thereof |
CN1244701C (en) * | 1995-10-17 | 2006-03-08 | 生化酶股份有限公司 | Cellulases, genes encoding them and uses thereof |
US6723549B2 (en) * | 1995-10-17 | 2004-04-20 | Ab Enzymes Oy | Cellulases, the genes encoding them and uses thereof |
EP0937138B1 (en) * | 1996-09-17 | 2006-04-26 | Novozymes A/S | Cellulase variants |
EP1735438A2 (en) * | 2004-04-12 | 2006-12-27 | Catalyst Biosciences | Cleavage of vegf and vegf receptor by wild-type and mutant proteases |
US7741093B2 (en) * | 2005-04-29 | 2010-06-22 | Ab Enzymes Oy | Cellulases and their uses |
BRPI0609906A8 (en) * | 2005-04-29 | 2017-11-21 | Ab Enzymes Oy | cellulase fusion protein, its production process and detergent composition containing it, expression vector, host cell, enzyme preparation, fading and bio-finishing processes and methods of treating cellulosic fiber containing textile material to treat fiber or pulp derived from wood and to improve the quality of animal feed |
FI118340B (en) * | 2005-04-29 | 2007-10-15 | Ab Enzymes Oy | New cellulase fusion protein comprises a cellulase core, and a linker and/or cellulose-binding domain (CBD), useful in textile industry, e.g. biostoning or biofinishing, or as detergent composition or as enzyme preparation |
US9410135B2 (en) * | 2010-09-15 | 2016-08-09 | The Regents Of The University Of California | Thermophilic mutants of Trichoderma reesei endoglucanase I |
KR20140018890A (en) * | 2011-02-09 | 2014-02-13 | 노보자임스 에이/에스 | Cellulase enzyme mixtures for depilling and uses thereof |
FI127093B (en) * | 2014-10-27 | 2017-11-15 | Ab Enzymes Oy | Fungal endoglucanase variants, preparation and use thereof |
EP3313990A4 (en) * | 2015-06-26 | 2019-01-23 | Novozymes A/S | Biofinishing system |
EP3377620A4 (en) * | 2015-11-16 | 2019-05-08 | Novozymes A/S | Cellulase variants and polynucleotides encoding same |
WO2017106676A1 (en) * | 2015-12-18 | 2017-06-22 | Danisco Us Inc | Polypeptides with endoglucanase activity and uses thereof |
EP3653706A1 (en) * | 2018-11-13 | 2020-05-20 | AB Enzymes Oy | Fusion protein |
-
2018
- 2018-12-17 CA CA3084907A patent/CA3084907A1/en active Pending
- 2018-12-17 WO PCT/FI2018/050935 patent/WO2019122520A1/en active Search and Examination
- 2018-12-17 BR BR112020011352-2A patent/BR112020011352A2/en unknown
- 2018-12-17 KR KR1020207020182A patent/KR102413168B1/en active IP Right Grant
- 2018-12-17 EP EP18892262.9A patent/EP3728579A4/en active Pending
- 2018-12-17 CN CN201880082135.3A patent/CN111670250B/en active Active
Also Published As
Publication number | Publication date |
---|---|
BR112020011352A2 (en) | 2020-11-17 |
KR102413168B1 (en) | 2022-06-24 |
WO2019122520A1 (en) | 2019-06-27 |
EP3728579A1 (en) | 2020-10-28 |
KR20200105844A (en) | 2020-09-09 |
CN111670250A (en) | 2020-09-15 |
EP3728579A4 (en) | 2021-12-01 |
WO2019122520A8 (en) | 2020-10-01 |
CN111670250B (en) | 2024-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11946078B2 (en) | Polypeptides with endoglucanase activity and uses thereof | |
KR102413168B1 (en) | Variant of fungal cellulase | |
EP3502243A1 (en) | Variants of fungal cellulase | |
US20220002697A1 (en) | Fungal Cellulase Variants With Improved Stability | |
CN113166746B (en) | Fusion proteins | |
US9994836B2 (en) | Fungal endoglucanase variants, their production and use | |
EP1305432A2 (en) | Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same | |
US6407046B1 (en) | Mutant EGIII cellulase, DNA encoding such EGIII compositions and methods for obtaining same | |
US10570383B2 (en) | Variants of fungal cellulase | |
US20220251529A1 (en) | Improved Mannanase Variants | |
CN114657166A (en) | Additional endoglucanase variants and methods | |
WO2020193532A1 (en) | Cleaning composition having amylase enzymes | |
US20220170001A1 (en) | Amylase Enzymes | |
US20220162576A1 (en) | Amylase enzymes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20200605 |
|
EEER | Examination request |
Effective date: 20200605 |
|
EEER | Examination request |
Effective date: 20200605 |
|
EEER | Examination request |
Effective date: 20200605 |
|
EEER | Examination request |
Effective date: 20200605 |
|
EEER | Examination request |
Effective date: 20200605 |